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ABSTRACT 
Plasmodium is a genus of parasites causing malaria, a virulent protozoan infection in humans 
resulting in over a million deaths annually. Treatment of malaria is increasingly limited by 
parasite resistance to available drugs. Hence, there is a need to identify new drug targets and 
authenticate antimalarial compounds that act on these targets. A relatively new therapeutic 
approach targets proteolytic enzymes responsible for parasite‟s invasion, rupture and hemoglobin 
degradation at the erythrocytic stage of infection. Cysteine proteases (CPs) are essential for these 
crucial roles in the intraerythrocytic parasite. CPs are a diverse group of enzymes subdivided into 
clans and further subdivided into families. Our interest is in Clan CA, papain family C1 
proteases, whose members play numerous roles in human and parasitic metabolism. These 
proteases are produced as zymogens having an N-terminal extension known as the prodomain 
which regulates the protease activity by selectively inhibiting its active site, preventing substrate 
access.  A Clan CA protease Falcipain-2 (FP-2) of Plasmodium falciparum is a validated drug 
target but little is known of its orthologs in other malarial Plasmodium species. This study uses 
various structural bioinformatics approaches to characterise the prodomain‟s regulatory effect in 
FP-2 and its orthologs in Plasmodium species (P. vivax, P. berghei, P. knowlesi, P. ovale, P. 
chabaudi and P. yoelii). This was in an effort to discover short peptides with essential residues to 
mimic the prodomain‟s inhibition of these proteases, as potential peptidomimetic therapeutic 
agents. Residues in the prodomain region that spans over the active site are most likely to 
interact with the subsite residues inhibiting the protease. Sequence analysis revealed 
conservation of residues in this region of Plasmodium proteases that differed significantly in 
human proteases. Further prediction of the 3D structure of these proteases by homology 
modelling allowed visualisation of these interactions revealing differences between parasite and 
human proteases which will lead to significant contribution in structure based malarial inhibitor 
design.  
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CHAPTER ONE 
1. INTRODUCTION 
1.1 MALARIA 
Malaria is the most dreadful protozoan infection in humans resulting in over a million deaths 
each year and is responsible for enormous economic burden in endemic regions (Ettari et al. 
2010). The control of malaria is increasingly limited by resistance of the parasite to available 
drugs. Thus there is a need for identification of new drug targets and validation of potential 
antimalarial compounds that act on these targets (Rosenthal et al. 1991). Malaria is caused by the 
Plasmodium parasite; there are five Plasmodium species that cause malaria in humans namely: 
Plasmodium falciparum, Plasmodium vivax, Plasmodium knowlesi, Plasmodium ovale and 
Plasmodium malariae (White 2008). Other species of Plasmodium including Plasmodium 
berghei, Plasmodium yoelii and Plasmodium chabaudi are known to cause malaria in rodents.  
 
Among the five species of Plasmodium parasites that infect human beings P. falciparum is 
justifiably the most virulent due to high levels of mortality with which it is associated. However 
the other human malaria causing Plasmodium species seem to be less studied and neglected in 
the light of P. falciparum. P. vivax has an estimated global burden of ~80-100 million clinical 
cases per annum, it is the most widely distributed human malarial parasite causing extensive 
morbidity. Most cases originate from Southeast Asia and the Western Pacific, a significant 
number also occur in Africa and South America. Though often considered a benign and self-
limiting infection, there is increasing evidence of the overall burden, economic impact and 
severity of disease from P. vivax (Price et al. 2007). The species P. knowlesi has a 24 hour life 
cycle, hence daily schizont rupture rapidly increases parasite load and even a short delay in 
accurate diagnosis, treatment and management may lead to increase in complications (Cox-Singh 
et al. 2008). P. knowlesi is encountered widespread in Malaysia and has been found in Thailand 
and China (White 2008). P. ovale is a relapsing malaria parasite with a latent liver stage that 
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often persists for many months and secondary infections can later be generated. Its course of 
parasitemia is short in comparison to other human infecting malarial parasites. P. ovale’s natural 
distribution is in sub-Saharan Africa and the islands of the West Pacific and there many other 
reports of its presence throughout the world (Collins et al. 2005). Therefore though neglected in 
comparison to research efforts of P. falciparum the other human malarial Plasmodium species 
are of medical importance and hence they were included in this study. The mice infecting 
Plasmodium species P. berghei, P. yoelii and P. chabaudi are important as they provide 
experimental models for studying malarial disease processes in vivo, thus they were also 
included in this study. 
 
1.1.1 Infection and lifecycle 
Malaria is spread to humans by the infected female anopheles mosquito that inoculates the 
parasites (sporozoites) into the subcutaneous tissue or directly into the bloodstream. Sporozoites 
migrate to the liver and invade hepatocytes where they replicate asexually yielding thousands of 
merozoites. Merozoites are released into blood circulation where they invade red blood cells 
beginning the erythrocytic cycle. The intraerythrocytic parasite by asexual replication produces 
about 20 mature merozoites that are then released to invade other erythrocytes. This can lead to 
thousands of parasite infected red-blood cells in hosts circulation and causes manifestation of 
disease symptoms that may be fatal if not treated. A small portion of the merozoites are 
converted into sexual forms of the parasite known as gametocytes that are essential for 
transmission of the disease from host to the vector thus completing the lifecycle (Miller et al. 
2002).   
 
1.1.2 Erythrocytic stage of Plasmodium infection 
Clinical manifestation of malaria begins at the erythrocytic stage of infection. The asexual 
parasites (merozoites) invade and multiply within erythrocytes that eventually rupture releasing 
more merozoites into circulation. The erythrocytic parasites reach high numbers in circulation 
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causing increased hemolysis leading to clinical symptoms of malaria including fever, malaise, 
fatigue, nausea, vomiting, diarrhoea, anaemia and jaundice. The intra-erythrocytic parasites take 
up the host‟s erythrocyte cytosol, into its own food vacuole and breaks down hemoglobin to 
provide necessary amino acids for parasite protein synthesis (Sijwali et al. 2004). The invasion 
and rupture of erythrocytes; allowing entry and egress of parasites as well as the hydrolysis of 
hemoglobin are processes involving the cooperate activity of various classes of malarial 
proteases (Figure 1.1) (Rosenthal 1998). Among these proteases are cysteine proteases, which 
have been identified to play a key role in the breakdown of hemoglobin as well as erythrocyte 
rupture (Rosenthal 2004). Other proteases involved include: aspartic proteases (plasmepsin I, II, 
IV and HAP) and metallo proteases involved in hemoglobin hydrolysis. Serine proteases 
(Subtilase I and Subtilase II) are associated with parasite‟s invasion and rupture of erythrocytes. 
This study will focus on cysteine proteases, due to their crucial role in the Plasmodium life cycle 
(Figure 1.1).  
 
Figure 1.1 Erythrocytic stage of infection, showing the proteases involved at the various stages of erythrocyte 
invasion, hemoglobin degradation and erythrocyte rapture (Rosenthal 1998). Diagram of intraerythrocytic cycle was 
adopted from the (http://medic19.blogspot.com/ ) webpage; the diagram was edited accordingly. 
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1.2 CYSTEINE PROTEASES 
Proteases are a group of enzymes that catalyse the hydrolysis of peptides. Proteases are grouped 
on the basis of their catalytic mechanisms and substrate specificity. The main catalytic classes 
include serine, threonine, aspartate, metallo and cysteine protease (Grzonka et al. 2001). 
Cysteine proteases are of interest to this study as they are essential in the life cycle and 
pathogenicity of many protozoan parasites and are targets for new anti-parasitic drugs (Rizzi et 
al. 2011). Cysteine proteases have an essential Cys residue in the active site that mediates 
hydrolysis of peptide bonds via a nucleophilic Cys thiol-group in a catalytic dyad. The sulfhydryl 
(-SH) group of Cys side chain and the imidazole of an active site His residue give rise to a 
thiolate-imidazolium charge relay dyad. This dyad is frequently but not always stabilized by a 
conserved Asn residue (Rosenthal 2004).  
 
Protease activity is not only determined by the three residues (Cys, His and Asp) forming the 
catalytic triad, but by other adjacent residues known as subsites residues (Schechter 2005). The 
active site of a protease has a dual function of binding the substrate and catalyzing the reaction. 
The efficiency of these two roles dictates the specificity of the protease towards ligand. It is thus 
possible to determine details on the active site by studying the kinetics of the protease towards 
different substrates (Schechter & Berger 1967).  
 
Cysteine proteases of parasitic organisms are categorized into clans namely: clan CA, CB and 
CC (McKerrow 2002). This study focuses on clan CA cysteine proteases also referred to as 
„papain-like‟ proteases that utilize Cys, His and Asn residues in their active sites. Clan CA 
proteases are well characterized in many organisms, the first of these was characterised from the 
papaya fruit hence the name papain. Clan CA is further subdivided into families based on 
sequence identities and similarities; family C1 (Papain family) and family C2 (calpain-like) 
(Lecaille et al. 2002). Majority of parasite proteases belong to the family C1 (Papain family) that 
is comprised of three subclasses: the cathepsin-L-like, cathepsin-B and cathepsin-F-like 
proteases (Rosenthal 2004).  
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Falcipains are the best characterised cysteine proteases in P. falciparum, there are four known 
falcipains: falcipain-1 (FP-1), falcipain-2 (FP-2), falcipain-2B (FP-2B) and falcipain-3 (FP-3) 
(Rosenthal 2004). Falcipains belong to the family C1 (Papain family) proteases and are within 
the cathepsin-L-like subclass (Wu et al. 2003).  
1.2.1 Functions of cysteine proteases in Plasmodium parasite 
Cysteine protease specific inhibitors have been used to determine the functions of falcipains in 
Plasmodium as being; invasion and rupture of erythrocytes as well as hemoglobin degradation 
(Wegscheid et al. 2010). FP-2 is the best characterised falcipains, its specific biologic role in the 
parasite was determined by the knock-out of FP-2 gene in recombinant parasites. Hemoglobin 
hydrolysis was altered in the FP-2 knockout parasites demonstrating the crucial role of FP-2 in 
hemoglobin hydrolysis and validating is as a drug target (Sijwali et al. 2004). Hemoglobin 
hydrolysis is the best characterised function of falcipains. The intraerythrocytic parasite takes up 
the host‟s erythrocyte cytosol transporting it via the cytostome to an acidic food vacuole, where 
hemoglobin is degraded (McKerrow 2002). Hemoglobin is hydrolysed, its heme component is 
converted to hemozoin pigment and globin is hydrolysed to its constituent amino acids. 
Hemoglobin hydrolysis is necessary to provide amino acids for parasites own protein synthesis 
(Francis et al. 1997). The breakdown of hemoglobin also enables maintenance of the 
erythrocyte‟s osmotic stability preventing premature erythrocyte rupture and provides space for 
the growing intraerythrocytic parasites. FP-2, FP-2B and FP-3 have also been implicated in 
hemoglobin degradation (Sijwali et al. 2006).  
 
Erythrocyte invasion by Plasmodium parasites involves the action of cysteine proteases on the 
erythrocyte cell surface. FP-1 specific inhibitors have been shown to block parasites invasion of 
erythrocytic host in culture (Blackman 2004). The third role of falcipains in the intraerythrocytic 
parasite is erythrocyte rupture. Falcipains facilitate erythrocyte membrane destabilization hence 
allowing parasite‟s escape from the erythrocyte confines (Blackman 2008). Studies using E-64 
cysteine protease inhibitor have shown that the inhibitor blocks lysis of the parasitophorous 
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vacuole membrane that encloses the parasite within the erythrocyte. Hence falcipains act against 
proteins associated with the parasitophorous vacuole and erythrocyte cell membranes to enable 
rupture and completion of the intraerythrocytic cycle (Rosenthal 2004).  
1.2.2 Structural properties of FP-2 
Papain-like cysteine proteases are typically synthesised in an inactive zymogen form to prevent 
potentially harmful premature proteolysis (Lecaille et al. 2002). The zymogen is comprised of an 
N-terminal extension of the mature enzyme (mature domain) known as the prodomain. The 
prodomain serves a regulatory role in the protease during secretory transport. It inhibits the 
protease by spanning over the active site hence preventing substrate access to the catalytic 
residues (Chowdhury et al. 2002). The zymogen structure is depicted in (Figure 1.2), the 
prodomain (purple) spanning over the active site (red) in the mature domain (green). The 
prodomain binds to the active site in the direction opposite to that of regular substrate binding, 
hence it is resistant to hydrolysis. Activation of the protease occurs by cleaving off the 
prodomain (Jean et al. 2003).  
 
The prodomain in falcipains has been found to be unusually longer that other Papain-family 
proteases (Sijwali et al. 2002). Other than its regulatory role, the falcipain prodomain is also 
known to have a role in intracellular trafficking as well as stabilizing the protease in denaturing 
alkaline pH environments (Cygler et al. 1997). The prodomain structure of cathepsin-L-like 
proteases is known to have 2 α-helices at its N-terminal: (α-1 helix and α-2 helix) intersecting at 
~60  (Figure 1.2). This is followed by a short α-3 helix that anchors the prodomain to the active 
site of the mature domain. The C-terminal section of the prodomain overlays the groove between 
the left and right lobes of the mature domain (Figure 1.2) (Godat et al. 2005).There is currently 
no available structure for the zymogen form of falcipains. However the crystallographic structure 
of the mature domain of FP-2 protease has been solved at a resolution of 3.1 Å (Hogg et al. 
2006). FP-2 mature domain adopts a fairly typical papain-like structure, having a left and right 
lobe. The left lobe is predominantly alpha helical, while the right lobe comprises of antiparallel 
beta sheets and peripheral helices. The active site catalytic residues Cys-285, His-417 and Asn-
447 (FP-2 numbering) are located at the junction between the left and right lobes (Ettari et al. 
2010)  as depicted in (Figure 1.2).  
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Figure 1.2 Structural features of Plasmodium cysteine protease, the structure was attained by homology 
modelling of FP-2 (see Chapter 3.3.4). The mature domain is shown in green, the active site is shown in red located 
between the left and right lobe of the protease. The N-terminal „nose like‟ projection and C-terminal insert „β-
hairpin‟ protrusion are indicated. The N-terminal extension (prodomain) that is responsible for protease inhibition is 
shown in purple lying over the active site and the groove between the left and right lobes. 
 
FP-2 has some unique features that are unusual to the Papain family. There is a 17 amino acid 
„Nose like‟ projection at the N-terminal of the mature domain of the protease, it is implicated to 
be involved in protease folding (Ettari et al. 2010). FP-2 also has a 14-residue „β-hairpin‟ 
protrusion known as the „arm‟, extending away from the protease surface, which is thought to be 
a hemoglobin binding motif (Hogg et al. 2006). These two features are the cause of the 
significantly larger dimensions of FP-2 in comparison to other Papain family cysteine proteases. 
The unique „Nose like‟ projection at the N-terminus of mature domain have a chaperone like 
activity allowing proper folding of the mature FP-2 in absence of its prodomain (Sijwali et al. 
2002). Studies suggest that these unique features of FP-2 are also found in its orthologs in other 
Plasmodium species and are essential for protease folding, activation and substrate binding 
(Wang et al. 2006). 
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1.2.3 Cysteine protease chemotherapy 
Malarial proteases are attractive drug targets against malaria due to their critical role in the 
parasite‟s infection and lifecycle. The treatment of experimental models of parasitic disease with 
cysteine protease inhibitors such as vinyl sulfones, peptidyl aldehydes and peptidyl fluoromethyl 
ketones has provided important proof of the drug target concept. However these inhibitors are 
not selective for the parasite enzyme, hence they may lead to toxicity as they also inhibit the host 
enzyme (McKerrow 1999). This poses the challenge in drug design as it is difficult to design an 
inhibitor specific to the parasite enzyme. The complexity of chemotherapy against cysteine 
proteases is due to abundant presence of these enzymes in viruses, prokaryotes and higher 
organisms. These enzymes also have broad substrate specificity making it difficult to inhibit 
individual proteases. 
 
Studies on inhibitor selectivity for parasite proteases suggest that host cells are less sensitive to 
cysteine protease inhibitors at the concentrations used in cultures or in in vivo studies (Selzer et 
al. 1999). As parasites appear to take up and concentrate inhibitors more efficiently than host cell 
organelles. Concentrations of proteases within host‟s cell are significantly higher than in the 
parasites hence even if few proteases are inhibited there may be limited toxicity to the host. In a 
malaria animal model, a fluoromethyl ketone that inhibits falcipain blocked P. vinckei protease 
activity in vivo after a single subcutaneous dose and cured 80% of murine malaria infections 
when administered for four days (Rosenthal 1998). However due to the challenge of low 
selectivity of most chemotherapeutic agents, there is a need for development of highly selective 
inhibitors with minimal toxic effects on the hosts. 
 
1.2.4 Prodomain inhibitory effect on cysteine proteases 
Though cysteine proteases are promising therapeutic targets there has been limited ability to 
attain inhibitors that are selective for the parasite protease. Hence there are efforts in developing 
alternative biologic inhibitors. One approach is based on the fact that parasitic cysteine proteases 
are synthesised as zymogens with N-terminal peptide chain extensions (prodomains) (Figure 
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1.1). Prodomains regulate the catalytic domain activities during secretory transport; preventing 
possibly damaging premature activation. The prodomains of cysteine proteases in Papain family 
are specific inhibitors of their cognate proteases. Therefore there is much interest in developing 
inhibitors that mimic this prodomain selective inhibition of proteases (Scott et al. 2010). One of 
the approaches is to synthesize small fragments of peptides that span the prodomain and assess 
their ability to inhibit the mature enzyme and thus identify residues specifically interacting with 
the active site (Sijwali et al. 2002). In a study small recombinant prodomain peptides of FP-2 
were designed and used to evaluate their antimalarial activity (Korde et al. 2008). One of the 
expressed peptides PP1 (-89aa – 75aa) was shown to significantly inhibit FP-2 in a dose 
dependent manner, the peptide also showed ability to translocate into the infected erythrocyte 
and inhibit FP-2 in-vitro. As a result of peptide inhibitor treatment, clusters of merozoites 
enclosed in a delicate membrane covering were observed within the erythrocytes. This was 
indicative of inhibited erythrocyte rupture hence merozoites did not exit the RBC confine. 
Prodomain peptide treated parasites also showed accumulation of undigested hemoglobin 
indicating inhibited hemoglobin hydrolysis (Korde et al. 2008).  
 
However studies on the structure of FP-2 prodomain show that this inhibitory peptide PP1 occurs 
at the α-1 helix in the N-terminal of the prodomain (see Chapter 2.3.2). Therefore in its native 
zymogen form peptide PP1 is not in interaction with the active site and is likely not responsible 
for specific inhibition. Hence a better understanding of the structural features and binding modes 
of these prodomains to their target cysteine proteases will provide valuable information for the 
development of effective and highly selective inhibitors (Carmona et al. 1996). 
 
1.2.5 Structural analysis and homology modelling 
To enable studying of the prodomain-mature domain interactions in the proteases mentioned it 
was essential that the 3D structure be available. This would allow for the visualisation of residue 
interactions and comprehensive interaction analysis. There are millions of protein sequences in 
the various sequence databases, but only a few tens of thousands of protein structures solved by 
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X-ray crystallography, NMR and electron microscopy in the Protein Data Bank (Berman et al. 
2000). This is because of the difficulty of isolation and solving of 3D protein structures. The goal 
of protein modelling is to predict a structure from its sequence with an accuracy that is 
comparable to the structure achieved experimentally. This allows for rapidly generated in silico 
protein models useful in structure-based drug design, analysis of protein function and study of 
protein interactions. Homology modelling is an alternative way to obtain structural information if 
experimental techniques are unsuccessful. Many proteins are either too large for NMR analysis 
or cannot be crystallized for X-ray diffraction. Homology modelling involves identifying 
appropriate homologs of known protein structure, called templates, alignment of the target 
(protein to be modelled) sequence with the template structures, model building and refinement, 
and validation (Tastan et al. 2008). This study will thus use homology modelling to predict the 
3D structure of the FP-2 and its orthologs in P. vivax, P. knowlesi, P. ovale, P. berghei, P. yoelii 
and P. chabaudi 
 
1.3 PROBLEM STATEMENT AND JUSTIFICATION 
Malaria is the world‟s most important parasitic disease infecting 300-500 million people and 
resulting in over a million deaths annually, mainly among children in sub-Saharan Africa. The 
control of malaria is increasingly limited by the parasite‟s resistance to available drugs hence 
there is a need for new strategies for antimalarial therapy. Falcipains are promising drug targets 
for malaria treatment. Studies on FP-2 have shown its role of hemoglobin hydrolysis as well as 
erythrocyte invasion and rupture of the intraerythrocytic parasite. Given the crucial role that FP-2 
support in the Plasmodium parasite it has been validated as drug targets. Cysteine proteases 
within the Papain superfamily have broad substrate specificity. This poses a challenge in drug 
design as chemotherapeutic agents developed against them have poor selectivity towards 
parasitic cysteine protease over the human cysteine protease (Shah et al. 2011). There is a need 
to design protease inhibitors that are specific to the parasite protease. Prodomain regions of 
cysteine proteases have been shown to inhibit their cognate enzymes specifically and selectively 
(Korde et al. 2008). Studying the inhibitory interactions of the prodomain with the mature 
enzyme, would reveal the essential residues for selective protease inhibition. These can further 
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be developed as short recombinant peptide inhibitors specific against the protease and potential 
as peptidomimetic therapeutic agents. 
Currently only two studies have been done on prodomain inhibition of FP-2 (Korde et al. 2008 , 
Pandey et al. 2009). Little is known of prodomain inhibition in the orthologs of FP-2 in other 
Plasmodium species: P. vivax, P. knowlesi, P. ovale P. berghei, P. yoelii and P. chabaudi. As 
well as their 3D structures of these orthologs remain unknown. Fewer studies have also been 
done on the other falcipains FP-1, FP-2B and FP-3. This study seeks to fill this knowledge gap 
by homology modelling of the 3D structures of the orthologs of FP-2 in the six Plasmodium 
species and in FP-2B and FP-3, showing prodomain to mature domain interactions. The study 
will use the known crystallographic structures of select papain-family cysteine proteases as 
templates for homology modelling. Unlike P. falciparum, in vitro culture is unavailable for the 
other human malarial Plasmodium species under study, making structural studies more 
appropriate. This study will analyse the sequences and obtained structures of the malarial 
proteases against select human papain family proteases (Cathepsin-H, -K, and -L). This is to 
observe for significant differences between parasite and human proteases. The results obtained 
will go a long way into broadening knowledge of structure based antimalarial drug design. 
 
1.4 SPECIFIC OBJECTIVES 
1. Retrieval of FP-2 and its orthologs from protein sequence databases by reverse BLAST 
and identification of appropriate templates for model building. 
2. Sequence alignment analysis and phylogenetic analysis 
3. Model building, refinement and validation of target cysteine proteases  
4. Study inhibitory interactions of the prodomain to the mature domain in the obtained 
cysteine protease models. 
5. Identify sequence and structural differences between Plasmodium and human cysteine 
proteases that are useful in development of specific peptide inhibitors 
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CHAPTER TWO 
2. SEQUENCE ALIGNMENT AND ANALYSIS 
Falcipain-2 (FP-2) is a papain family cysteine protease from P. falciparum. This chapter focuses 
on the identification of FP-2 orthologs in six Plasmodium species namely: P. vivax, P. knowlesi, 
P. ovale P. berghei, P. yoelii and P. chabaudi. The protein sequences of FP-2 and its orthologs 
are analysed via multiple sequence alignment (MSA) and phylogenetic analysis. This is to 
discover conserved motifs and residues potentially involved in protein function. Papain family 
cysteine proteases are ubiquitous enzymes occurring both in the Plasmodium parasites and its 
human host. The Plasmodium protease sequences are thus compared against their human 
homologs revealing differences between parasite and human proteases significant in antimalarial 
drug design.  
 
2.1 INTRODUCTION 
Proteins are fundamental in controlling and implementing biological processes in living 
organisms. This includes enzymatic catalysis, immunological responses, mechanical support, 
coordinated motion, endocrine function and storage; hence deeper understanding of protein 
structure and function is of essence. In living organisms the flow of genetic information from the 
gene to protein level is similar. Genetic information encoded in DNA or RNA sequences is 
translated to amino acids that build up proteins. The knowledge of genome sequences has been 
central to understanding the proteins encoded in organisms and their functional implications 
(Tatusov et al,. 1997). Advances in next generation sequencing technology has allowed for 
increased speed and efficiency of DNA sequencing, making it easier to obtain the amino acid 
sequences of proteins (Zhang et al. 2011). Proteins with similarity in sequence of amino acids are 
divergent from a common ancestral gene and usually have similar structural and functional 
properties (Altschul 1998). 
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Evolutionary relatedness of protein families is referred to as homology. Homologs diverge from 
a common ancestor and homology is inferred by sequence, structural or functional similarity. 
Homologs are of three types: orthologs, paralogs and xenologs. In most cases orthologs retain 
similar functional characteristics as they evolve; hence identifying orthologs to a novel protein is 
essential to its function prediction (Tatusov et al. 1997). Characterising a novel or unknown 
protein sequence involves comparing it against a sequence database to identify annotated 
homologs. These annotated homologs can then offer reference for functional and structural 
analysis of the unknown protein (Pierri et al. 2010).  
 
There are several publicly accessible biological databases to which new nucleotide and amino 
acid sequences are submitted by the scientific community. These databases store and organise 
sequence and structural data allowing for its easy retrieval. The available databases range from 
primary databases that hold raw sequence data, secondary databases having curated and 
annotated data and specialized databases that focus on information of specific research interest. 
Among the major biological database resources is the National Center for Biotechnology 
Information (NCBI) database (http://www.ncbi.nlm.nih.gov/) and the RCSB Protein Data Bank 
(PDB) (http://www.rcsb.org/pdb/home/home.do) (Rose et al. 2011). To ease retrieval of record 
in these databases, search tools based on similarity searching are used. 
 
Sequence comparison is the starting point of structural and functional analysis of proteins. 
Comparing sequences provides insight on the functional and evolutionary inference of a newly 
sequenced protein with proteins already present in biological databases. These eases annotation 
of new proteins as biological knowledge from well characterised homologs can be conferred. 
Sequence comparison is achieved through alignment, the process by which regions of similarity 
and residue to residue correspondence is searched between sequences (Xiong 2006). Sequence 
alignment depicts evolutionary relatedness of the proteins involved, extensive similarity between 
sequences points out likely common ancestral origin. Analysis of sequence alignment is based on 
sequence similarity and identity. Sequence identity is when matching residues align, while 
sequence similarity refers to alignment of residues that are similar in physiochemical properties. 
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If sequence similarity is high enough it can infer sequence homology and consequently likely 
structural similarity (Krissinel 2007).  
 
2.1.1 Alignment strategies and algorithms 
Sequence comparison can either be by global and/or local alignment. Global alignment is carried 
out across the complete length of the sequences involved, while local alignment finds and aligns 
local regions of similarity between the sequences (Altschul 1998). Local alignment is ideal for 
distantly related sequences that contain only similar domains. Dynamic programing is an 
effective algorithm for attaining optimal sequence alignment. Needleman-Wunsch algorithm for 
global alignment and Smith-Waterman algorithm for local alignment employ dynamic 
programming (Needleman et al. 1970). Dynamic programing seeks to find the maximum 
matches that can be aligned between two protein sequences while accounting for mismatches. 
These methods assign scores to matches, define costs for substitutions and gaps and compute the 
alignments, the higher the total score is the better the alignment is (Morgenstern et al. 1996). 
Dynamic programming is computationally expensive and time consuming hence unsuitable for 
aligning multiple sequences. 
 
To assign the various scores dynamic programming uses scoring matrices, to determine the 
probability of a residue been substituted for another in an alignment based on similarity in 
physiochemical properties. The most common scoring matrices used are Point Accepted 
Mutations (PAM) and Blocks of Amino Acid Substitution Matrix (BLOSUM) which are based 
on real multiple sequence alignments (Henikoff 1992) and have been shown to outperform 
matrices based purely on the physiochemical properties of amino acids. PAM scoring matrix is 
based on the fact that amino acids substitution during the evolutionary process tends to conserve 
physiochemical properties. Thus amino acids of the same size, charge or hydrophobicity are 
more likely to be substituted for each other. The PAM-1 matrix is based on a real dataset by 
calculation of the likelihood of one substitution per 100 residues. Higher PAM matrices are 
derived by multiplying PAM-1 by itself, thus PAM-40 results from multiplying PAM-1 by itself 
40 times. The PAM 40 matrix means that in 100 residues there are 40 substitutions, which is 
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ideal in aligning closely related sequences that have 70-90% similarity. Hence as the 
evolutionary distance between sequences increases higher numbered PAM matrices are used 
(Wheeler 2002). BLOSUM scoring matrix is derived from conserved un-gapped blocks of 
protein sequence alignments. The frequency of all possible amino acid pairs in every column of 
the block are numerated and used to calculate a matrix. Closely related sequences in the block 
are most likely to increase the frequency of certain amino acids hence creating bias. This is 
resolved by clustering similar sequences beyond a certain threshold in a block; hence clustering 
at 80% similarity threshold gives BLOSUM-80. As the clustering threshold reduces it 
incorporates more distantly related sequences hence lower BLOSUM matrix numbers detect 
more distant related sequences (Henikoff 1992). Scoring matrices score matches and 
substitutions in alignment; additional gaps costs are charged where residues align with nulls the 
best alignment has the least costs and the highest score.  
 
2.1.2 Database similarity search tools 
There are software tools used to search for homologs in biological databases all based on 
sequences similarity realized through alignments.  Basic Local Alignment Search Tool (BLAST) 
is one of the most frequently used programs for searching for homologs in biological databases. 
BLAST uses heuristic algorithms to rapidly find optimal alignments in biological databases (Ye 
et al. 2006). BLAST displays results as a list of the sequence matches ordered by the statistical 
significance measured by the alignment score and the expectation value (E-value). A higher 
alignment score depicts a better alignment while the E-value is a measure of the probability that 
the alignment is a random match from the database. The lower the E-value is the higher the 
biological significance of the alignment. The BLAST tool is available as a stand-alone program 
as well as through a variety of web servers, the NCBI-BLAST been one that is commonly 
accessed (http://blast.ncbi.nlm.nih.gov/Blast.cgi). NCBI-BLAST offers a variety of databases 
search methods like BLASTP that screens protein databases using a protein query sequence. 
There are some refinements to the BLAST tool that enhance the program‟s speed and sensitivity. 
The PSI-BLAST tool is one such enhancement that makes use of position specific scoring 
matrices (PSSM) to increase sensitivity in detecting remote homologs (Altschul et al. 1998). 
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HHpred server is another fast database search tool for detecting protein homology across a wide 
range of protein databases (http://toolkit.tuebingen.mpg.de/hhpred). HHpred server facilitates 
sensitive and speedy database searches allowing detection of remote homologs and protein 
structure prediction. The server achieves high sensitivity and accuracy through its HHsearch 
resource that makes use of Hidden Markov models (HMM-HMM comparison) (Söding et al. 
2005). Database searches are performed by first querying the sequence against non-redundant 
databases using several PSI-BLAST iterations to align with homologs. PSI-BLAST generates 
sequence profiles that are used for secondary structure prediction by PSIPRED; hence results of 
the final PSI-BLAST alignment are inclusive of predicted secondary structure (Jones 1999). This 
final alignment with structure prediction details is used to create a profile HMM that has position 
specific amino acid, insertion and deletion probabilities (So  ding 2005). For each column in the 
alignment a HMM profile column is added that holds the probabilities of a match, insert and 
delete state. A match state is the probabilities of the 20 amino acids allowed in that column, 
while the insert and delete states model the probability of an insert or deletion at the position. 
The insert and delete probabilities are converted to position specific gap penalties used in HMM-
HMM alignments (Eddy 1998). HHsearch is then used to query the consensus HMM profile 
against a selected database by performing HMM-HMM comparison. HMM profiles are better for 
homolog detection than traditional position-specific scoring matrices (PSSMs) and achieve better 
alignments; their increased sensitivity is due to position specific gap penalties (So  ding 2005). 
HHpred results display the alignment and alignment statistics including the probability of 
homology to the query, percentage identity, similarity and the E-value.  
 
2.1.3 Retrieval of orthologs from biological databases 
Retrieving of sequences from biological databases is based on sequence similarity. The BLAST 
tool is useful in detecting homologs. BLAST hits with high sequence identity and E-values lower 
than 1e-6 (1*10-6) are likely to be homologs to the query sequence (Xiong 2006). Reverse 
BLAST is an approach used to identify orthologs of a query sequence from a biological database, 
it is a two-stage process involving a forward and reverse BLAST step. In the forward BLAST, 
the query sequence is used to perform a BLAST search narrowed to the species from which 
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orthologs are targeted. The first hit from the forward BLAST results is used as a query in the 
reverse BLAST step. If the reverse BLAST returns the initial query sequence as its best hit, the 
two sequences are thus considered to be orthologs (Mazumder et al. 2005). Orthologs commonly 
have extensive sequence and structural similarity.  
 
There are homologs and orthologs gene databases that can also be searched for putative 
orthologs (Zhou et al. 2007). The NCBI Clusters of Orthologous Groups of proteins (COG) 
(http://www.ncbi.nml.nih.gov/COG/) is a database containing orthologs of unicellular organisms 
currently holding 66 genomes. HomoloGene (http://www.ncbi.nlm.nih.gov/homologene) is a 
homologs sequence database as well as OrthoMCL DB (http://www.orthomcl.org/cgi-
bin/OrthoMclWeb.cgi) which is a database of orthologs holding 150 genomes from both 
eukaryotic and prokaryotic species (Chen et al. 2006). These databases are specialized to hold 
orthologs and have search tools like BLASTO making it possible to precisely search and retrieve 
orthologs (Zhou, et al. 2007). 
 
2.1.4 Multiple sequence alignments 
Sequence alignment as discussed earlier is the initial point in functional and structural 
characterisation of a protein. Homologs of a given protein can be identified through database 
similarity searches and comparing several homologs gives a better view of the conservation 
within a family of organisms. Multiple sequence alignment (MSA) helps to reveal ancestral 
relationships between organisms and conserved residues and motif that may be of functional 
importance (Taylor 1998). Heuristic approaches have been developed to carry out MSA, this 
includes progressive alignments, iterative alignment and consistency based alignment 
(Thompson et al. 1999). Progressive MSA is built up in a stepwise manner by first aligning 
closely related sequences and subsequently adding more distantly related sequences. There are a 
number of MSA programs based on progressive alignments, CLUSTAL been the most 
commonly used. CLUSTAL MSA are built up progressively by initial pairwise alignments 
between all possible sequences, based on their alignment scores a guide tree is constructed using 
the Neighbour joining method. The guide tree is used to build the MSA by aligning closely 
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related sequences and adding sequences progressively according to their location in the guide 
tree (Chenna et al. 2003). T-Coffee is a consistency based aligner, known to be slow but has 
increased accuracy in alignment. Consistency based approach is where T-coffee program creates 
a library comprised of local and global pairwise alignments. These pairwise alignments are 
generated by other alignment programs like CLUSTAL (Local alignments) and LALIGN (global 
alignments). The program evaluates the local and global alignments produced, allocating weight 
to the alignments based on sequence identity.  This is followed by library extension of the 
combined local and global alignments (Niun et al. 2006).  T-Coffee then uses the library to come 
up with a position specific scoring matrix used to construct a guide tree, which is used to direct a 
MSA using the progressive approach (Di Tommaso et al. 2011). T-Coffee eliminates errors in 
the early stages of pairwise alignment that can be propagated through the MSA hence improving 
the progressive method (Pei et al. 2007).   
 
Profile multiple alignment with local structure (PROMALS3D) is a MSA alignment program 
that performs both sequence and structural alignments (Pei et al. 2008). It is an improved 
consistency based method that initially performs pairwise alignment of similar sequences scoring 
alignments using the BLOSUM62 scoring matrix to give groups of pre-aligned sequences. A 
representative sequence is selected from each group and using PSI-BLAST its homologs are 
searched from the Uniprot non-redundant reference databases facts (UNIREF90) and Protein 
structure prediction server (PSIPRED) for secondary structure prediction (Pei et al. 2007). 
Amino acids sequence profiles are derived from the PSI-BLAST and PSIPRED they are used to 
come up with a consistency scoring function. The representative sequences are then aligned 
progressively using the consistency scoring function and all the pre-aligned sequences are 
incorporated to form a complete MSA (Pei et al. 2008). 
 
Multiple sequence alignment based on fast fourier transform (MAFFT) is a fast consistency 
based approach of MSA, which builds a preliminary alignment using the progressive method 
then refines it iteratively to produce an optimal alignment (Pei, Grishin 2007). Distance between 
all pairs of sequences to be aligned is calculated and used to generate a guide tree using 
Unweighted pair group method with arithmetic mean (UPGMA) method. MAFFT uses fast 
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Fourier transform (FFT) analysis to rapidly detect segments of sequence similarity; FFT 
algorithm aligns the sequences by progressive alignment based on the guide tree (Katoh et al. 
2002). The alignment is further refined by generating a better distance matrix based on the 
pairwise alignments of the initial guide tree. The new distance matrix is used to generate a guide 
tree for progressive alignment this process is iterated till no better scoring alignment is attained 
(Katoh et al. 2005). MAFFT has the advantage of speed and producing precise MSA. 
 
MUSCLE is a MSA program that is based on refinement of the progressive method to get 
optimal alignments. MUSCLE uses Kmer a distance measure between un-aligned pair of 
sequences to generate a distance matrix, clustered by UPGMA to produce a guide tree (Tree-1). 
Kmer is a measure that does not require alignment giving this first stage the advantage of speed. 
The guide tree generated (Tree-1) is used to guide a progressive alignment producing a draft 
MSA. The draft MSA is rather substandard as a result of the Kmer distance estimation (Edgar 
2004). MUSCLE thus generates an improved tree using kimura distance, which is a measure of 
evolutionary distance between aligned sequences that corrects homoplasy. Homoplasy is the 
effect of multiple mutations at one position of a sequence that affects accurate evolutionary 
distance prediction. Kimura distance is a more accurate measure of evolutionary distance than 
Kmer and is used to generate a guide tree (Tree-2). By progressive alignment a MSA is 
generated guided by tree-2, computing of the alignment is only done for branching orders of 
Tree-2 that differ from Tree-1.  
 
2.1.5 Phylogenetic analysis 
To evaluate the evolutionary history of the protein sequences, molecular phylogenetic analysis is 
done. This allows for studying of evolutionary divergence of sequences using a tree branching 
pattern, referred to as a phylogenetic tree. The general assumption is that divergence is 
bifurcating hence a predecessor branches out into two descendants. Construction of a 
phylogenetic tree involve multiple sequence alignment of the sequences involved, this need be 
done accurately. Evolutionary models are then used to approximate the evolutionary distances 
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between sequences and a distance matrix is constructed that is used to generate a phylogenetic 
tree (Xiong 2006).  
MEGA5 is one of the numerous  programs available for phylogenetic analysis. MEGA5 is used 
for the analysis of DNA and protein sequences, the program has tools that align sequences, 
estimate distance between sequences and generate phylogenetic trees. The program performs 
alignment of the data using in built MUSLE or CLUSTAL alignment programs or can accept 
data that is already aligned. Estimating evolutionary distances between the protein sequences is 
of importance to assessing the sequence divergence; to do this MEGA5 has statistical models 
otherwise known as evolutionary models. Statistical models like Jones-Thornton-Taylor (JTT) 
and Dayhoff produce accurate evolutionary distance estimations by accounting for amino acid 
substitution between sequences and correcting homoplasy. The calculated distances are 
converted into a distance matrix used by an algorithm to build a phylogenetic tree (Kumar et al. 
2004).  
 
Neighbour joining (NJ) is one of the distance based algorithms used in constructing of 
phylogenetic tree. It involves joining all the taxa into a single node forming a star-like tree, the 
most closely related pair forms the first node and the next closely related taxa is linked to the 
first node this is progressive till all taxa have been added creating a complete tree (Saitou et al. 
1987). To ensure the most optimal tree topology for a given set of taxa is achieved, several trees 
are generated each having a different initial pair for the first node and the tree that optimally fits 
the evolutionary distance is selected. Authenticity of the tree in representing phylogeny of the 
data is then statistically evaluated using the bootstrap test (Kumar et al. 2004). Bootstrapping 
involves iteratively altering the data-set and generating trees that are then compared against the 
original tree to test for robustness. Bootstrap values are indicative of the confidence levels of the 
topology. MEGA5 allows visualisation of the constructed tree in a Tree Explorer. Phylogenetic 
trees give a clear view of how various species have evolved within a family, showing the 
evolutionary divergence or similarity of species involved. 
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2.2 METHODS 
Protein sequences of FP-2 and its orthologs in six Plasmodium species were retrieved, aligned 
and analysed. Plasmodium sequences are compared to those of human papain family homologs. 
The procedures and tools used are discussed here.  
 
2.2.1 Sequence retrieval 
The protein sequence of FP-1 (XP_001348727.1), FP-2 (XP_001347836.1), FP-2B 
(XP_001347832.1) and FP-3 (XP_001347833.1) were retrieved from the NCBI-Entrez database. 
FP-2 sequence was used as a query for the reverse BLAST, to retrieve its orthologs in six 
species: P. vivax (taxid:5855), P. berghei str. ANKA (taxid:5823), P. knowlesi (taxid:5850), P. 
ovale (taxid:36330), P. chabaudi chabaudi (taxid:31271) and P. yoelii yoelii str. 17XNL 
(taxid:352914). The NCBI BLASTP tool was used for the reverse blast with default alignment 
parameters of BLOSUM-62 scoring matrix, a gap existence and extension cost of 11 and 1 
respectively and a word-size of 3. 
 
The search for FP-2 orthologs using the reverse BLAST approach was done in two stages; the 
forward BLAST that points to the orthologs in other species and the reverse BLAST that ideally 
should return FP-2 as the best hit. However the reverse BLAST returned FP-3 as the best hit 
instead of FP-2. Therefore it is likely that the retrieved orthologs (Table 2.1) are more closely 
related to FP-3 than FP-2. To establish this sequence identity of the retrieved orthologs to FP-2 
and FP-3 is determined (Tables 2.2). A search was done in the PlasmoDB and HomoloGene 
database to verify orthologs results obtained from the NCBI. The most probable FP-2 orthologs 
were selected and used for sequence alignment (Table 2.1). Homologs of FP-2 from the H. 
sapiens species were also retrieved from NCBI. The retrieved human protease sequences were 
within the papain family, cathepsin-L-Like sub-class; there were essential for comparative 
analysis of parasite versus human proteases. All retrieved sequences were analysed using the 
InterPro server (http://www.ebi.ac.uk/Tools/pfa/iprscan/) to scan for functional domains. 
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2.2.2 Sequence alignments 
MSA of the Plasmodium sequences were generated to observe for conserved residues and 
domains within this genus of proteases. Comparative analysis of Plasmodium against human 
homologs cathepsin-L1, cathepsin-K and cathepsin-H was done. MSA was carried out using 
MAFFT (http://toolkit.tuebingen.mpg.de/mafft/), T-Coffee (http://tcoffee.crg.cat/), CLUSTALX, 
PROMALS3D (http://prodata.swmed.edu/promals3d/promals3d.php) and MUSCLE 
(http://www.ebi.ac.uk/Tools/msa/muscle/) alignment programs. The alignments generated by the 
various programs were compared and the most accurate alignment was selected. None of the 
used alignment programs is entirely acurate, most generated alignments would have regions that 
are poorly aligned. The poorly aligned regions have significant effect on the general quality of 
the alignment. Hence it is necessary to select the best possible alignment.   
 
The alignment programs were accessed via web servers and default alignment parameters were 
used. A fasta file holding all the sequences to be aligned was uploaded to the program and the 
MSA was run automatically. An initial alignment was done using the entire protease sequences; 
to give a view of the local regions of similarity across the full length sequences (Appendix A-I). 
The sequences were then trimmed to the prodomain and mature domain segment of interest. This 
allowed for better alignment that focussed on interest regions. Alignments were viewed using 
BioEdit (Hall 1999) alignment viewer.  It was observed that PROMALS-3D alignment program 
gave the most accurate / best quality alignments. This MSA program is not entirely error free 
hence it is necessary to manually edit the alignment and improve its quality. This is done by 
examining the aligned residues and hand adjusting of residues so as to attain a close to ideal 
alignment. Analysis was done by identifying conservations unique to Plasmodium that are likely 
to influence selective propeptide inhibition of these species.  
 
2.2.3 Phylogenetic analysis 
MEGA5 was used to generate a NJ phylogenetic tree that depicted the evolutionary relationships 
between the Plasmodium and human proteases. PROMALS3D alignment was used as the dataset 
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for tree generation. Contiguous regions of the alignment with minimal gaps were selected as the 
dataset (Appendix A-II). The Neighbour joining algorithm was used to generate a phylogenetic 
tree. The parameters used were JTT statistical model and 1000 replicates of bootstrapping 
analysis were done to determine the confidence level at the inner nodes of the topology.  
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2.3 RESULTS AND DISCUSSION 
Results attained from protease sequence retrieval, sequence and structural alignment and 
phylogenetic analysis are discussed in this section. All residue numbering used in analysis is in 
reference of FP-2. The proteases are referred to by their common names indicated in (Table 2.1) 
2.3.1 Retrieval of orthologous sequences 
FP-2 orthologs in Plasmodium species were searched from the NCBI database by reverse 
BLAST (Table 2.1). The HomoloGene and PlasmoDB database searches reflected similar FP-2 
orthologs authenticating our results. Homologs of FP-2 from the H. sapiens species that are 
within the cathepsin-L-like subclass were also retrieved. All the retrieved cysteine proteases will 
hence forth be referred to by their common names as indicated in (Table 2.1) 
Table 2.1 Summary of FP-2 and its homologs retrieved from NCBI. The table shows the accession number, 
common name and length of the sequence as well as the prodomain and mature domain regions of interest used in 
sequence alignment.  
Species name Accession 
Number 
Common name Number of Amino acids 
Total Pro-
domain 
Mature 
domain 
P. falciparum 3D7 XP_001347836.1 Falcipain-2 484 155-243 244-481 
P. falciparum 3D7 XP_001347832.1 Falcipain-2B 482 153-241 242-479 
P. falciparum 3D7 XP_001347833.1 Falcipain-3 492 161-249 250-489 
P. vivax AAT36263.1 Vivapain-2 487 157-245 246-484 
P. knowlesi strain H XP_002259152.1  495 163-251 252-490 
P. berghei strain ANKA XP_680416.1  470 144-229 230-467 
P. yoelii yoelii str. 17XNL XP_726900.1  472 146-231 232-469 
P. chabaudi chabaudi AAP43630.1 Chabaupain-2 471 144-230 231-468 
P. falciparum 3D7 XP_001348727.1 Falcipain-1 569 215-306 307-567 
P. ovale AAC47037.1  317 1-78 79-310 
Homo sapiens AAL23962.1 Cathepsin H 323 18-103 104-307 
Homo sapiens NP_001903 Cathepsin L1  333 25-113 114-331 
Homo sapiens NP_000387 Cathepsin K  329 22-113 114-327 
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All retrieved sequences were from the clan CA proteases and within the Papain family C1, 
Cathepsin-L-like subfamily. BLAST as well as InterPro database searching revealed two 
functional domains associated with this family: peptidase C1A Papain family (mature domain) 
and proteinase inhibitor-129 cathepsin propeptide (prodomain). The respective prodomain and 
mature domain regions of the sequence are indicated in (Table 2.1) above. Reverse BLAST 
results showing the first two hits attained is represented in (Table 2.2). Sequence identity of the 
of the ortholog sequences to FP-2 and FP-3 was also attained.  
Table 2.2 Reverse BLAST results indicating the first and second hit returned by the NCBI-BLAST tool and 
the percentage identity of the mature domain of each ortholog to FP-2 and FP-3. 
 
FP-3 been the first hit in the reverse BLAST results likely suggests that the sequences were more 
closely related to FP-3 than to FP-2 based on the E-value and BLAST bit scores. To establish 
this sequence identity of the retrieved sequences to FP-2 and FP-3 were compared. Most of the 
sequences have higher sequence identity to FP-3 than to FP-2, with an exception of FP-2B. 
Further sequence and phylogenetic analysis was done to determine if the higher similarity to FP-
3 was significant to the functionality of the proteases structure and function. 
Ortholog  Accession 
number 
REVERSE BLAST % Identity of sequences 
of FP-2 and FP-3 
First hit second hit FP_2 FP_3 
Falcipain-2 XP_001347836.1 FP_2 FP_2B 100 52.8 
Falcipain-2B XP_001347832.1 FP_2B FP_2 93.1 53.0 
Falcipain-3 XP_001347833.1 FP_3 FP_2 52.8 100 
Vivapain-2 AAT36263.1 FP_3 FP_2 47.8 54.2 
P. knowlesi  XP_002259152.1 FP_3 FP_2 43.8 47.6 
P. berghei XP_680416.1 FP_3 FP_2 40.5 40.7 
Chabaupain-2 AAP43630.1 FP_3 FP_2 40.6 41.0 
P. yoelii XP_726900.1 FP_3 FP_2 39.3 40.7 
Falcipain-1 XP_001348727.1 FP_2B FP_2 18.7 20.1 
P. ovale AAC47037.1 FP_1 FP_2 36.1 36.1 
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2.3.2 Sequence alignment and analysis 
Multiple sequence alignments of the retrieved proteases were carried out using MUSCLE, 
MAFFT, T-Coffee, CLUSTALX and PROMALS3D, the best alignment was selected. 
PROMALS3D gave the best alignment, given that it combines sequence and structural 
constraints ensuring alignment of best fit without gaps in non-loop regions. Unlike the other 
alignment programs PROMALS3D alignment used structural constraints from the homologous 
structures included in the MSA. Alignments by the other programs are provided in the 
(Appendix A-III).The sequence identity between aligned sequences was not very high so to 
ensure best fit of alignment PROMALS3D results were manually inspected and slight hand 
adjustment was done. Hand adjustment was guided by HHpred structure prediction analysis (see 
more in the Appendix A-IV).  The alignments clearly showed conserved regions in the 
prodomains of Plasmodium proteases (Figure 2.1). 
 
Figure 2.1 Alignment of the prodomain sequences of human and Plasmodium proteases in section A and B 
respectively. Two 3D structures from the papain family are added to the alignment (1BY8 and 2O6X) (in section A), 
the α-helices and beta sheets positions relative to 206X structure are indicated. The residues highlighted in grey are 
indicative of strict conservation in both species and the asterisk „*‟ indicates the aligned regions of high similarity in 
both species. The vertical line „|‟ indicate aligned residues whose conservation is unique to Plasmodium. A nine 
residue insert at N-terminal of Plasmodium is marked out in red 
The alignment showed residue conservation in certain regions indicated by asterisks and grey 
highlighting in (Figure 2.1). P. ovale sequence was notably shorter than the other Plasmodium 
sequences which may be attributed to its incomplete sequencing. It was also observed that the 
sequences of FP-1 and P. ovale were less similar to the other Plasmodium sequences due to their 
distant evolutionary relationship as depicted by the phylogenetic tree in (Figure 2.5). The 
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prodomain sequences of Plasmodium proteases were markedly longer than those of human 
proteases; having a conserved nine residue N-terminal extension (red outlined in Figure 2.1). 
This nine residue extension (155-164) LMNNLESVN is unique to the Plasmodium species and 
is likely to have a significant function in the Plasmodium proteases. A study suggests that this 
insert region of the prodomain is responsible for protease inhibition (Korde et al. 2008) (see 
Chapter 1.2.4). However this is highly unlikely given its location in the prodomain structure.  
 
The general 3D structure of the prodomain in cathepsin-L-like proteases has an N-terminal mini-
domain comprising of 2 α-helices intersecting at 60 degrees (Figure 2.2). This is followed by a 
section of prodomain chain that covers the groove between the two lobes of the mature enzyme 
blocking the active site and is affixed by a short α-3 helix (Cygler & Mort 1997). These 
structural regions were mapped onto the sequences and the nine residue extension in 
Plasmodium was found to occur in the α-1 helix region, which as depicted in (Figure 2.2) is not 
in direct interaction with the active site and is least likely to cause inhibition. The α-1and α-2-
helices are known to be key in maintaining structural integrity of the prodomain, while α-3-helix 
lies adjacent to the active site (red in Figure 2.2) region causing inhibition (LaLonde et al. 1999). 
 
Figure 2.2 Papain family prodomain structure in purple showing the α-1, α-2 and α-3 helix sections. α-3 helix is shown to 
directly overlay the active site (red) and is most likely to have inhibitory interactions with the residues of the active site. The 
structure is attained by homology modelling of FP-2 (see Chapter 3.3.4). 
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Conserved residues in the α-1, α-2 and α-3 helix segments of the prodomain were closely 
examined and significant differences between Plasmodium and human proteases in these 
sections were observed (Table 2.3). 
Table 2.3 Conserved residues in the prodomains of Plasmodium (grey) and human (green) proteases. The table 
represents select substitutions observed across the sequences (blank spaces indicate residue conservation). Residues 
are coloured by physiochemical properties: green-hydrophobic, red-polar acidic, blue-polar basic, black-polar 
uncharged  
Protease α-1 helix  α-2 helix  α-3 helix and surrounding loop regions 
conservation 165 
F 
166 
Y 
168 
F 
174 
K 
 181 
E 
185 
R 
186 
F 
189 
F 
192 
N 
196 
I 
200 
N 
 209 
K 
210 
G 
212 
N 
214 
F 
216 
D 
221 
E 
222 
F 
223 
K 
224 
N 
225 
K 
226 
Y 
227 
L 
228 
S 
230 
K 
Falcipains-2           V    E            R 
Falcipains-2B     j      V    E       S     R 
Falcipains-3              R       R S    N  
Vivapain-2    R     Y             K    T  
P. knowlesi         Y            E K    T  
P. berghei                      M    N  
Chabaupain-2           V           M R   N  
P. yoelii                      M    N  
Falcipain-1  F     K        K     L  E Y F K K L 
P. ovale - -     K  Y K     K    D L   Y F K T L 
Cathepsin-H W E W     W L     M A       H     Q 
Cathepsin-K W T W   D  W R     L A     V V Q  M T G  
Cathepsin-L1 W K W R    W R     M A  L   I R Q V M N G E 
The α-1 helix region was found to have conserved Phe residues at position 165 and 168 in 
Plasmodium species, both residues are replaced by Trp in the human protease; these residues are 
proposed to form hydrophobic interactions with Phe 189 that is highly conserved in α-2 helix of 
the Plasmodium prodomain (Table 2.3). These three Phe residues form a hydrophobic core that is 
vital in stabilizing the prodomain structure (Pandey et al. 2009). Another hydrophobic residue 
Try 166 is observed to be conserved in the α-1 helix of the Plasmodium proteases. However this 
residue is substituted for Glu and Lys which are polar charged residue in human protease 
cathepsin-H and cathepsin-L1 respectively. Phe 186 is also relatively conserved in the α-2 helix 
of Plasmodium species and is thought to support the hydrophobic core; it however aligns to Arg 
a polar basic residue in human cathepsin-K and -L1. The structure of the prodomain is sustained 
by residue interactions via hydrophobic interactions and hydrogen bonding (Pandey et al. 2009). 
This facilitates inhibitory association of the prodomain to the mature domain. Hence these 
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dissimilarities in key hydrophobic residues are likely to have effect on the structures of the 
Plasmodium versus human prodomain affecting how they occlude the mature domain. 
 
There are two well-known conserved motifs in the prodomains of cathepsin-L-like proteases 
ER(F/W)N(I/V)N (residue 189-200) and GNFD (residue 210-216) (Wiederanders et al.2003), 
these are observed to be conserved in both Plasmodium and human prodomains. These two 
conserved motifs are essential in maintaining the secondary structure of the prodomain. The 
ERFNIN motif lies in the α-2 helix fostering interactions with residues in α-1 helix to ensure 
proper prodomain structure and appropriate inhibitory contact to the catalytic domain. The 
ERFNIN motif is well conserved in the α-2 helix of both Plasmodium and human proteases 
(Table 2.3). The GNFD motif is found in the loop region right before α-3 helix (Table 2.3). This 
motif is conserved in both species with an exception of the Gly-210 residue which is replaced by 
a non-polar residue Ala in all the human proteases; it also aligns to Glu in FP-2 and FP-2B and 
Lys in P. ovale and FP-1. The Asp residue of the GNDF motif is highly conserved and is 
interacts with the Arg-181 residue of the ERFNIN motif to stabilize α-3 helix (Wiederanders et 
al. 2003).  
 
The prodomain region spanning the groove between the two domains of the mature protease 
occludes the active site by interacting with the residues in the substrate binding sites. This region 
corresponds to the α-3 helix and the loop region after it in the prodomain (Figure 2.2). A 
conserved motif FKNKYLT is found in this region from residues 222-228 these residues are 
highly similar in the Plasmodium proteases. A pattern of conservation of this motif was 
observed, in the three murine species P. berghei, P. chabaudi and P. yoelii the motif was 
FKMRYLN. In 2 Plasmodium species P. ovale and FP1 the motif residues were LK(N/E)YFKK. 
In the proteases FP-2, FP-3, FP-2B, vivapain-2 and P. knowlesi the motif residues were 
FK(S/K)KYLT. This motif was seemingly conserved in accordance to the three major 
Plasmodium clusters depicted by the phylogenetic tree in (Figure 2.5). These prodomain residues 
are likely to be in interaction with residues of the substrate binding pocket (subsites) in the 
mature domain, hence obstructing substrate access. Subsites are the residues flanking the 
catalytic triad (Cys, His and Asn), which interact with ligands. FP-2 has 4 known subsites S1, 
S1', S2 and S3 (Figure 2.4) (Shah et al. 2011).  
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The prodomain residues identified to occupy and inhibit the S1' subsite in human cathepsin-L1 
and cathepsin-K are Met 92 and Asn/Thr 93 (Chowdhury et al. 2002), these residues align with 
hydrophobic residues Try-226 and Leu-227 respectively in the FKNKYLT motif of the 
Plasmodium species (Table 2.3). This is a significant difference in the S1' inhibition of human 
and parasitic proteases. In cathepsin-L1 and cathepsin-H the prodomain residues Gln-96 and 
Glu-86 respectively are known to occupy and inhibit S1 subsite. These align with basic polar 
residues Lys/Arg-230 in the Plasmodium species; hence there are substantial differences in the 
prodomain residues occupying the various subsites in Plasmodium and human proteases. 
Knowledge of the prodomain residues key in selective inhibition of the various subsites in the 
proteases is of importance as these are potential in peptidomimetic drug design. The prodomain 
is known to have selective inhibition of its parent enzymes hence contrasts in residue interaction 
in parasite and human protease are essential to attaining selective antimalarial activity. 
 
Other noted divergences were: Lys-170 a basic polar residue is fully conserved in Plasmodium 
prodomains, however in aligns with Ser and Ala which are uncharged residues in the human 
cathepsin-H and cathepsin-L1 respectively. Lys-209 is also conserved in Plasmodium it aligns 
with hydrophobic residues Met in cathepsin-H and cathepsin-L1 and Leu in cathepsin-K. These 
residues within the prodomain mark out differences in human and Plasmodium that are likely to 
affect the structure of their prodomain and its interactions with the mature domain.  
 
Having analysed the prodomain sequences of the proteases, the mature domain was also analysed 
to identify residues that are around the active site that are likely to interact with the prodomain. 
The mature domain alignment of human and Plasmodium is shown in Figure 2.3. This alignment 
shows numerous conserved residues across Plasmodium and human proteases. The catalytic 
residues Cys-285, His-417 and Asn-447 (FP-2 numbering) are conserved in both species (Figure 
2.3). There is a 17 residue insert observed in the N-terminal of the Plasmodium proteases that is 
absent in the human cathepsin-L1, -K and -H proteases. The insert residues (244-261) are highly 
similar in Plasmodium species with an exception of FP-1 and P. ovale that have different residue 
composition (Figure 2.3).  
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Figure 2.3 Alignment of catalytic domain in Plasmodium and human species inclusive of two papain family 
protease structures 1BY8 and 2O6X. The regions highlighted in grey indicate strictly conserved residues and the 
asterisk „*‟ show regions of high similarity and conserved physiochemical properties in both species. The vertical 
line „|‟ shows indicates aligned regions with conservation of residues unique to Plasmodium species and different in 
human species. 
This N-terminal extension in Plasmodium is associated with „chaperone like‟ function, it enables 
folding of the mature protease to active conformation in absence of the prodomain (Sijwali et al. 
2002). A ten residue insert (429-438) exclusive to the Plasmodium species is also observed near 
the C-terminal (Figure 2.3). This insert is fairly similar in the Plasmodium species except in FP-
1and P. ovale where it is 15 residues longer and fairly different in amino acid residue 
composition. This insert is thought to be a hemoglobin binding motif (Pandey et al. 2005).                 
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FP-2 is known to have four disulphide bonds that are conserved in all the Plasmodium proteases 
(CYS 282-323), (CYS 316-357), (CYS 342-362), (CYS 411-472) (Hogg et al. 2006). The human 
proteases also show conservation of these Cys residues with an exception of (CYS 342-362) that 
is unique to Plasmodium. The unique Plasmodium disulphide bond (CYS 342-362) is essential in 
stabilising the structure of the mature domain in active conformation. Disulphide bond (CYS 
411-472) in Plasmodium forms the upper loops of the S2 and S1' binding sites in FP-2. Residues 
of the substrate binding pocket (subsites) in the protease sequences were analysed. Conservation 
of residues in the four subsites (Figure 2.4) were analysed in human and Plasmodium proteases 
(Table 2.4) 
 
Figure 2.4 Subsites in the Plasmodium proteases showing the four subsites (purple) around the catalytic residues 
(red) in the mature domain (light green) of FP-2. 
Table 2.4 Analysis of the subsite residues in the proteases highlighted in blue are the human proteases.  
Proteases S1 S1'  S2 S3 
Residue no. 
Falcipains-2 
Falcipains-2B 
Falcipains-3 
Vivapain-2 
P. knowlesi 
P. berghei 
Chabaupain-2 
P. yoelii 
Falcipains-1 
P. ovale 
Cathepsin-H 
Cathepsin-L1 
Cathepsin-K 
279      282      284      288       279 
Q        C        S         F        C 
Q        C        S         F        C 
Q        C        S         F        C 
Q        C        S         F        C 
Q        C        A        F        C 
Q        C        S         F        C 
Q        C        S         F        C 
Q        C        S         F        C 
Q        C        S         F        C 
Q        C        S         F        C 
Q        C        S         F        C 
Q        C        S         F        C 
Q        C        S         F        C 
395     416      418        419        448         449 
V        N        A         V          S         W  
V        N        A         V          S         W  
V        N        A         V          S         W  
V        N        A         V          S         W  
V        N        A         V          S         W  
V        N        A         V          S         W  
A        N        A         V          S         W  
V        N        A         V          S         W  
V        N        S         V          S         W  
V        N        S           -           -           -  
A        N        A         V          S         W  
A        D        G         V          S         W  
A        N        A         V          S         W 
286       392      321        325    327     328    329 
W         S         Y        G       L       I      N   
W         S         Y        G       L       I      N          
W         S         N        G       Y       I      T           
W         S         N        G       L       I      P           
W         S         T        G       F        I      P           
W         A        F        G       I         L     P            
W         A        D        G       I         L     P          
W         A         F        G       I         L     P          
W         N         F        G       H       P     F          
W         N         F        G       H       P     F          
W         A        Y        G       L        P     S          
W        A        E        G         L         M    D         
W         A        D        G       Y        M    T         
415     477      478       479 
L         D       A        F 
L         D       A        F 
P        E       A         Y 
P         E       A        Y 
P        E       A        L 
A       Q      G        Y 
A         Q      A        Y 
A         Q      G        Y 
L        E       V        F 
L          -        -          - 
V         C       A        S 
M        A       A        S 
L         L       A         S 
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FP-2 has 4 subsites S1, S1', S2 and S3 (Table 2.4), subsite residues were defined by selecting 
residues within 14Å from the catalytic residues Cys, His and Asp (Shah et al. 2011). Residues in 
subsite S1 and S1' were very well conserved in both Plasmodium and human proteases with an 
exception Asn-416 that is substituted for Asp in cathepsin-L1 (Table 2.4). Residues in subsite S2 
and S3 were observed to have more substitutions: Tyr/Phe-321 hydrophobic conserved residues 
in S2 of Plasmodium sequences were substituted for polar acidic Asp and Glu residues in 
cathepsin-L1 and cathepsin-K respectively. Reside Asp-477 is well conserved in subsite S3 of 
human-malarial Plasmodium proteases is substituted with hydrophobic residues Cys, Leu, Ala in 
cathepsin H, K and L1 respectively. Phe/Try-479 is conserved in subsite S3 of Plasmodium 
species with an exception of vivapain-2; it is substituted with Ser residue in human proteases. 
These variances in subsite residues between parasite proteases and their human host are useful in 
designing specific inhibitors. 
 
2.3.3 Phylogenetic analysis 
 
Figure 2.5 Phylogenetic tree of FP-2 and its orthologs in Plasmodium and human species based on a 
PROMALS-3D alignment in the (Appendix A-II). The Neighbour joining tree was generated using MEGA5. 
Bootstrap statistical analysis values at each inner node specify percentage probability of its occurrence. 
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The evolutionary relationship of the Plasmodium and human proteases was well observed. A 
region of the sequence alignment with minimal gaps that was likely to depict evolutionary 
relationship was used to generate the phylogenetic tree as shown in the (Appendix A-II). The 
Phylogenetic tree shows 4 clusters: P. ovale and FP-1 seemingly divergent from the other 
Plasmodium species. The second cluster holds the murine malarial Plasmodium species; P. 
berghei and P. yoelii branch from a common recent ancestor and are closely related to 
chabaupain-2. The third cluster is of human malarial proteases; FP-2 and FP-2B which are 
closely related to FP-3, vivapain-2 and P. knowlesi. The fourth cluster having human proteases: 
cathepsin-L1, cathepsin-K and cathepsin-H. From the analysis of sequence alignments it was 
noted that residue conservation was grouped in these four clusters. The prodomain region 
spanning over the active site was also conserved according to these clusters. Hence it is likely 
that for each of the clusters of Plasmodium proteases common peptide inhibitors can be 
designed. 
 
2.4 CONCLUSION 
FP-2 a cysteine protease in P. falciparum is a validated drug target for malaria. The prodomain 
of FP-2 is known to selectively inhibit the protease by obstructing the active site to substrate 
access. Knowledge of the prodomain residues key in selective inhibition of the mature enzyme in 
Plasmodium is of importance as these are potential in peptidomimetic drug design. The protein 
sequences of FP-2 and its orthologs in six Plasmodium species were analysed. The proteases 
were found to have a conserved motif in the prodomain section that spans over the active site. 
Alignment analysis showed that this motif was significantly different in residue composition to 
human proteases. The subsite residues in Plasmodium and human proteases were also analysed 
and variances were observed in the residue composition of subsite S2 and S3. These 
dissimilarities in human and Plasmodium are crucial to designing specific inhibitors that would 
target the parasite protease. This analysis was done on protein sequences of the proteases and it 
would be important to visualise structurally how these residues interact. Therefore there is a need 
to predict the structure of FP-2 and its orthologs to authenticate the results derived from 
sequence analysis. 
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CHAPTER THREE 
3. STRUCTURAL ANALYSIS 
In this chapter homology models of FP-2 and its orthologs are built to visualise interaction 
between the prodomain and mature domain. Structural analysis of the regulatory role of the 
prodomain to mature domain provides insight on the specific inhibition of these proteases. This 
knowledge will aid in discovery of short peptides that mimic this inhibition as potential 
antimalarial agents.  
3.1 INTRODUCTION 
The 3D structure of a protein is crucial to unveiling function of a protein at the atomic level. 
Protein structure reveals binding sites, domain interactions, ligand binding and spatial relations 
of subsite residues, these aspects are key to protein function. Advances in high throughput DNA 
sequencing technology have led to massive increase in generated sequenced data. The protein 
sequences currently available in biological databases number in the millions whereas the Protein 
Data Bank holds ~76, 000 protein structures as at October 2011.  It is practically impossible to 
attain the 3D structure of all novel proteins by experimental methods. Computational biology 
seeks to fill in this sequence to structure gap by predicting the structure and function of 
uncharacterised proteins (Pierri et al. 2010). The 3D structure of proteins is essential in 
determining their function and biological significance. Structural analysis of proteins is also 
known to play a major role in the drug discovery process (Nayeem et al. 2006). Protein structure 
comparison provides an effective way of finding distant evolutionary related homologs as 
structures are conserved to a higher degree than sequences (Gherardini et al. 2008). X-ray 
crystallography, nuclear magnetic resonance (NMR) spectroscopy and electron microscopy are 
experimental techniques used to generate the 3D structure of proteins. These techniques are 
laborious, time consuming and expensive, hence computational techniques like homology 
modelling are in use to predict the structure of proteins thus subsequently understanding their 
function.  
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3.1.1 Protein structure determination 
The experimental methods of protein structure determination X-ray crystallography, NMR and 
electron microscopy are well established and result in optimum and high quality structures (Di 
Luccio & Koehl 2011). X-ray crystallography is the most accurate technique giving high 
resolution protein structures. It involves purification and crystallization of the protein that is then 
exposed to X-rays. The electrons in the protein molecules cause diffraction of the X-ray beam, at 
different diffraction intensities and directions that are recorded as an electron density map. The 
electron density maps are interpreted to determine the location of each atom in the molecule and 
build the protein structure. Crystals are comprised of identical repeating units of the protein 
molecule referred to as the unit cell, hence amplifying the diffraction of X-rays. The geometry of 
the unit cell defines the direction of the diffracted beams and the position of atoms in the unit cell 
affect the intensity of diffraction (Wlodawer et al. 2008). The resulting structure is refined and 
validated. Quality of crystal structure is assessed by the resolution which is the level of detail at 
atomic level measured in Å. 
 
Nuclear magnetic resonance (NMR) spectroscopy is a method of determining structure of a 
protein in solution conditions. This allows studying of proteins in conditions close to their 
physiological state in living organisms (Wüthrich 2003). NMR capitalises on the magnetic 
properties of the atomic nuclei by placing the protein molecule in a magnetic field and probing it 
with radio waves. The resonance frequency is observed and used to characterise individual 
atomic nuclei. Computational tools are used to interpret the NMR data and build molecular 
structures that are refined and validated (Di Luccio et al. 2011).  
 
Electron microscopy (EM) is a method based on electron diffraction. This method has the 
advantage of deriving data on 3D structure of macromolecules that are either too large or 
heterogeneous for NMR or X-ray crystallography methods (Zhou 2008). The protein sample is 
prepared either by cryo-freezing (cryoEM) or negative staining with heavy metals for good 
contrast. EM involves exposing the protein to an electron beam; some energy is absorbed by the 
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atoms within the protein and the rest is transmitted forming a 2D image. 3D reconstruction is 
done to the image computationally using methods like single particle reconstruction. 3D images 
are refinement and verification is done to attain an optimum image. Though experimental 
techniques in structure determination are reliable, structures of many proteins potential as drug 
targets are currently unavailable. These structures are essential in assessing „druggability‟ of the 
proteins. Therefore homology modelling which is an easier and faster method of attaining protein 
structure is employed to bridge the gap untill experimentally obtained structures are available 
(Blundell et al. 2006). 
 
3.1.2 Homology modelling 
Homology modelling is based on the principle that the 3D structure of a protein can be predicted 
given its sequence is similar to proteins of know experimentally determined structure. Homologs 
diverge from a common ancestor; over time accumulating non-destabilizing mutations hence 
their protein structures remains relatively similar. Similarity in the backbone structure of proteins 
increases with higher sequence identity (Bajorath et al. 1993). In the absence of experimentally 
derived 3D protein structure, homology modelling plays a major role in the processes of drug 
discovery and this is of interest to this study. The applications of homology modelling in the 
drug design process include: Identification and analysis of ligand binging sites, validation of 
these as drug targets and docking ligands to find ideal orientation of compounds in these sites 
(Hillisch et al. 2004). 
 
Modelling the 3D structure of a protein (target protein) involves a series of steps. To begin with 
is template identification, which involves searching protein structure databases for a homologous 
protein of known high-resolution experimentally determined 3D structure (template). The target 
and template protein sequences are aligned. The main chain of the target protein is modelled 
based on the coordinates of the template protein and varied regions unrepresented in the template 
protein are modelled as loop regions. The side chains atoms are built and the resulting model is 
refined, optimized and verified to assess the quality of the model (Di Luccio & Koehl 2011). 
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There are several tools available to automate the model building process. Modeller is an efficient 
homology modelling program that builds 3D models of protein structure from structural 
alignments and refines obtained models (Sali & Blundell 1993). This program is discussed in 
greater detail later in this chapter. 
 
3.1.2.1 Template selection 
A preliminary and essential stage in model building is selecting a favourable structural template. 
This involves searching the Protein Data Bank (PDB) for a temple that has high sequence 
similarity to the target protein. A template is assessed based on its structure resolution and 
sequence identity to the target protein this determines the quality of the resultant model. 
Templates with a sequence identity > 30% to the target protein are acceptable as the two proteins 
are considered to be homologs and are likely to have common 3D structure (Hillisch et al. 2004). 
Sequence identity between 30-50% between target and template protein results in high quality 
models that are satisfactory for drug target studies. Sequence identity of 15-30% is considered to 
be low; hence accurate alignment is required to identify homology between sequences. Models 
generated at 15-30% identity can be used for protein function studies (Hillisch et al. 2004). 
Sequence identity below 15% results in models which may not reliably represent the protein 
structure (Nayeem et al. 2006). In the case that there are many available possible templates, the 
one with the highest sequence identity, highest resolution and best coverage of the target protein 
is selected. If no particular template fully structurally represents the target, a combination of 
multiple templates can be used to model the various domains of the target protein (Moult 2005). 
 
Templates are searched from the protein structure databases using sequence similarity search 
tools such as PSI-BLAST, HHpred and PDB sequence search. PSI-BLAST is a more sensitive 
BLAST search that employs position specific scoring matrices (PSSM) profiles. This enables 
retrieval of distant homologs, with biologically significant sequence similarity hence increasing 
chances of detecting a structurally annotated homolog (Altschul et al. 1997). However PSI-
BLAST is a sequence comparison method and may not effectively detect homologs of known 
structure, hence protein structure prediction methods like HHpred are used. HHpred 
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(http://toolkit.tuebingen.mpg.de/hhpred) is a fast and highly sensitive server for structure 
prediction and detection of structurally annotated homologs (Söding et al. 2005). HHpred server 
searches several structural databases employing PSIPRED structural predictions and HHsearch 
(HMM-HMM comparison) increasing sensitivity to detect homologs (for further explanation see 
Chapter 2.1.4). HHpred results give a list of possible templates ordered by E-value; it also 
presents accurate structural alignments of the target to the various templates. The best template 
can then be selected based on resolution, sequence similarity to target and completeness of the 
structure.  PDB sequence search allows the user to use the target protein sequence as a query to 
search the PDB (Rose et al. 2011). The search gives a list of protein structures that have 
significant similarity to the target protein sequence; one can then choose a suitable template. 
 
3.1.2.2 Template-target alignment 
Having selected a suitable template(s), the sequences of the target and template are aligned. 
Accuracy of this sequence-structure alignment is a prerequisite for high quality of the resultant 
model. For optimum alignments structurally equivalent residues need to align, errors made in 
alignment of residues adversely distort the structure of the model (Venclovas 2003). Target to 
template alignment takes into consideration both the matching of similar and identical residues 
and structural correctness of the alignment. It is thus important to use alignment programs that 
incorporate protein structure prediction such as HHpred and PROMALS-3D (Söding et al. 2005), 
(Pei et al. 2008). HHpred alignment uses Hidden Markov model (HMM) profiles, which are built 
from MSA of proteins in the template family. HMM profiles are better at alignment than 
ordinary PSSMs. This is because HMM profiles incorporate information on position specific 
probabilities of inserts, deletions and amino acid matches hence ensuring that the alignment 
algorithm doesn‟t place gaps in structural regions (Dunbrack Jr. 2006). During alignment 
attention should be given to loop region and regions of low similarity between target and 
template that are more error prone. Final alignments produced by the alignment programs need 
be visually reviewed for any mistakes. Manual adjustments can also be done in misaligned 
regions to attain optimum alignments. 
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3.1.2.3 Model building 
Having attained suitable target-template alignment, the template is used as a guide for the main-
chain atom positions this is integrated with loop and side-chain building algorithms (Sali & 
Blundell 1993). Model building is based on the target-template structural alignment in regions 
where identical residues align, the templates main-chain and side-chain atom coordinates are 
copied to the model. In regions where aligned residues differ the main-chain atom coordinates 
are copied and the side chain is later built. In gap regions of the alignment, that have insertions 
and deletions, loops are modelled (Xiong 2006).  
 
Loops are mostly found on the surface of the protein as flexible structures connecting between 
secondary structures (α-helices and β-sheets) (Van & Blundell 1997). Loop regions are 
challenging to model as they represent regions of the target protein that are structurally different 
from the template. Loops are often biologically significant as they can be involved in the 
functional roles of the protein like protein-protein interactions (Di Luccio & Koehl 2011). There 
are two main approaches used to model loops: database search methods and ab initio methods. 
Database search methods involve; scanning databases of known protein structure (PDB) for 
protein segments that are of similar length and sequence with the target loop to be modelled. The 
protein segment need be compatible with the stem residues (end points of main-chain before and 
after the loop) of the target protein. The best protein segment having suitable orientation and the 
least steric clashes with the rest of the protein structures is used to model the conformation of the 
target loop. This loop prediction method is ideal for short-medium sized loops (Van & Blundell 
1997). Ab initio loop modelling approach involves randomly generating various conformations 
of the target loop and using an energy scoring function to get the best fit loop. Ab initio methods 
are effective for longer-sized loops and the accuracy of loop prediction depends on the effective 
sampling of conformational space and evaluation of conformational energy (Xiang et al. 2002). 
Various methods are used to sample conformational space including; molecular dynamic 
simulations and Monte Carlo conformational searches (Abagyan & Totrov 1994) ensuring 
optimum loop prediction.  
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Once the main-chain has been modelled using the template coordinates and loop building in gap 
regions, the side-chain conformations are then modelled. Side chain conformation is important 
especially in the active site region where the interaction of residues is key to the functionality of 
proteins. The side chains of residues are known to have preferential conformations or rotamers as 
observed in experimentally derived structures (Bower et al. 1997). The most frequently observed 
conformations for all 20 amino acids are stored in rotamer libraries. To increase speed and 
accuracy of deriving residue conformations, backbone dependant rotamer libraries have been 
developed. These libraries associate main-chain conformations with certain rotamers. To predict 
the side chain conformation these rotamer libraries are scanned and the most favourable 
conformations with minimal steric clashes and energy scores are selected (Di Luccio & Koehl 
2011).  
 
3.1.2.4 Model refinement 
The complete model needs to be refined and optimized in both geometric and energetic aspects 
so as to attain a structure of stable conformation. Model refinement involves energy 
minimization and regulating bond lengths and angles of atoms, in order to attain appropriate 
stereochemistry of the model without distorting its structural conformation (Levitt & Lifson 
1969). Local refinement of the structure occurs during loop and side chain building, energy 
scores are used to access local quality. This allows for detection are correction of errors at the 
residue level hence improving the model quality. Global refinement is then done to resolve 
structural irregularities in the entire protein structure. A stable protein conformation (native state) 
is known to be at local and global minimum of its surface potential energy (Summa & Levitt 
2007). Refinement requires methods that effectively sample the conformational space and 
identify near native-like model conformations. Molecular dynamics simulation (MD) techniques 
are used to identify near native states enhancing accuracy of conformations selected in the 
refinement process (Lee et al. 2001). These methods are incorporated into model building 
programs like Modeller ensuring that optimum models are generated. 
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3.1.3 Modeller a tool for model building 
Modeller is one of the most efficient comparative protein structure modelling programs (Kmiecik 
et al. 2007). Modeller is a script based program; given the structural alignment file in the pir 
format, the template atom coordinate files and a script file with the appropriate model building 
commands the program automatically builds the 3D models of the target (Narayanan Eswer 
2006). Modeller uses spatial restraints attained from the template (homology derived restraints) 
to guide model building of the target protein (Kosmoliaptsis et al. 2011). The forms of spatial 
restraints used were derived from databases of protein structural alignments, where relationships 
between equivalent main-chain dihedral angles and Cα-Cα distance of related proteins were 
obtained. These restraints work together with stereochemistry restraints on the bond length, bond 
angles and dihedral angles enforced by CHARMM22 to refine the models to proper 
stereochemistry (MacKerell Jr. et al. 1998). Modelling by spatial restraints is an efficient method 
of comparative modelling as in addition to homology derived restraints other restraints based on 
experimentally derived protein structure and general biological knowledge can be incorporated 
to the process enhancing model quality (Narayanan Eswer 2006). Modeller using its automodel 
class builds models automatically, going through the backbone, loop and side-chain building 
steps and finally refining the model. The program‟s output is the atom coordinate files of the 
models in the PDB format readable by visualisation programs like PyMol (Schrödinger, L.L.C. 
2010). Ordinarily several models of the same target are built, hence to select and evaluate the 
best model Modeller calculates the Discrete Optimized Protein Energy (DOPE) energy. The 
DOPE score is an atomic-distance-dependent, knowledge-based potential that is derived from a 
sample of native structures used to assess homology models. DOPE uses an enhanced reference 
state corresponding to non-interacting atoms in a heterogeneous sphere, whose size reflects that 
of the sample native structures (Shen & Sali 2006). DOPE score is calculated and normalized by 
the number of restraints acting on each residue giving a DOPE Z (normalised score). The model 
with the lowest normalised DOPE Z score is selected; models of medium to high accuracy 
typically have energy scores below -1 (Eramian et al. 2008). 
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3.1.4 Model validation 
Model validation entails assessing quality of the predicted model. Computational models are 
typically not as accurate as the true experimentally derived structure hence evaluation of the 
accuracy of models is import. Validation of proteins involves: checking of stereochemical 
properties, examining protein folding quality using energy calculations and assessing model 
compatibility with its amino acid sequence (Kosmoliaptsis et al. 2011). There are a variety of 
model quality assessment programs (MQAPs) available. 
 
MetaMQAPII (https://genesilico.pl/toolkit/unimod?method=MetaMQAPII) is a program used to 
assess quality of computational models of protein structure. Unlike most other MQAPs which are 
based on global evaluation of the protein structure, MetaMQAPII focusses on local areas of 
inaccuracy that are common in computational models. MetaMQAPII is a meta-predictor that 
combines results of 8 other validation programs; PROSA, VERIFY3D, ANOLEA, BALA, 
PROVE, PROQRES, REFINER and TUNE. This aims to combine strengths of different MQAPs 
whilst eliminating individual flaws. Most of the above MQAPs showed bias to trivial features 
including: residue depth in the structure, residue hydrophobicity. MetaMQAPII thus combines 
the various MQAPs and uses a multivariate regression model that controls bias to trivial 
parameters hence providing a better quality assessment tool (Pawlowski et al. 2008). 
MetaMQAPII scores predict the absolute deviation of C-α atoms (backbone atoms) in each 
residue of the model from its corresponding residue in the native protein structure; this is 
expressed as the root mean square deviation (RMSD) (Moult et al. 2007). MetaMQAPII also 
gives a Global Distance Test Total score (GDT_TS), which is a measure of the global structure 
similarity between proteins (Zemla 2003). GDT-TS score is dependent on the length of the 
protein; hence the optimum score varies with protein size.  MetaMQAPII generates a PDB file, 
in which it colors the structure by quality; colors are incorporating in the B-factor column 
enabling visualization of errors in the structure. A spectrum of colors ranging from blue to red is 
used where blue represents highly scored residues and red poorly scores residues. This eases the 
prediction of regions of lower quality in the model that can then be further refined (Pawlowski et 
al. 2008). 
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Structural Analysis and Verification server (SAVS) is a webserver that runs 5 different MQAPs: 
PROCHECK, VERIFY3D, WHAT_CHECK, PROVE, and ERRAT. This makes it possible to 
verify many qualities of a model at once (http://nihserver.mbi.ucla.edu/SAVES/). SAVS is user 
friendly allowing the user to upload the PDB file, select desired MQAPs and it then displays 
output of all the selected MQAPs. The programs of interest are discussed further. VERIFY3D 
(http://nihserver.mbi.ucla.edu/Verify_3D/) is a MQAP that uses a statistical approach to 
measures the compatibility of the 3D model to its amino acid sequence. This is done by 
characterizing each of the residues in the 3D model based on environment features like solvent 
exposure, area of side-chain that is buried by other residues and local secondary structure (Bowie 
et al. 1991). Based on these features each residue position of the structure is categorized in an 
environmental class. This results in the translation of the 3D structure to a 1D sequence 
representation of environmental class. A collection of high resolution structures is used as a 
reference to obtain scores for each of the 20 amino acids in different environmental classes; these 
are called 3D-1D scores. The 3D-1D scores are plotted against the residue number in a 21-
residues window to assess compatibility of the structure with protein sequence (Luthy et al. 
1992).  
 
PROCHECK (http://www.ebi.ac.uk/thornton-srv/software/PROCHECK/) is a MQAP that 
evaluates the stereochemical quality of a protein structure. This includes assessing the bond 
length, chirality and ψ and ϕ torsion angles. The output given by PROCHECK is Ramachandran 
plots analyzing overall and residue by residue geometry. A Ramachandran plot has coloring 
representing different regions where red represents the most favored region. The ideal is to have 
90% of the residues in the most favored regions (Yadav et al. 2010). 
 
PROSA (https://prosa.services.came.sbg.ac.at/prosa.php) this is a MQAP that uses knowledge-
based force fields to validate the quality of a model (Sippl 1993). These Knowledge based force 
fields are energy functions derived from statistical analysis of all experimentally determined 
protein structures in databases. This gives the statistical average energy function of correctly 
folded, stable proteins that can be used to assess correctness of modeled structures.(Sippl 
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1995).The program calculates the surface energy of the protein giving a Z-score (see Chapter 
3.1.3) that determines global model quality. The Z-score is interpreted by displaying it in a plot 
containing Z-scores of all experimentally derived protein structures. The protein Z-score can be 
observed from the plot to see if it is the desired range of native conformations (Wiederstein & 
Sippl 2007). PROSA also gives a local model quality energy plot, this plots energy scores against 
the amino acid positions over a 10 and a 40 residue window. Residues with positive energy 
values show erroneous parts of the structure.  
 
3.1.5 Prodomain – mature domain interaction analysis 
The 3D-structure of cysteine proteases in Plasmodium were attained via homology modelling 
and the inhibitory interactions between the prodomain and mature domain are analyzed. One of 
the tools used for this analysis is the Protein Interaction Calculator (PIC) server 
(http://pic.mbu.iisc.ernet.in/). The PIC server is used to identify various interactions between 
residues in a protein structure or between proteins in a complex. The interactions identified 
include: hydrophobic interactions, ionic interactions, disulphide bridges, aromatic-aromatic 
interactions, aromatic-sulphur interactions and cation interactions. The PIC server input is a 
protein coordinate file in the PDB format and the users are allowed to select which interactions 
are to be calculated. The program out puts all interactions identified in the protein(s) and these 
interactions can be visualized using a RasMol and Jmol interface (Tina et al. 2007). The PIC is 
also able to identify solvent accessibility that is if residues lie on the surface or are buried deep in 
the protein core this is made possible by calculating a depth parameter. The PIC server utilizes 
the HBOND program (Mizuguchi et al. 1998) to identify hydrogen bonds between main-chain 
atoms, main-chain to side-chain atoms, and between side-chain atoms. The user can specify 
distance cutoffs in angstroms for identifying any of the interactions between residues (Tina et al. 
2007). 
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3.2 METHODS 
Homology modeling of FP-2 and its orthologs is done and the interactions of prodomain-mature 
domain are analyzed. The procedures followed and methods used are discussed here. 
3.2.1 Template identification 
The target protein sequences of (FP-2, FP-2B, FP-3, P.knowlesi, vivapain-2, P. berghei, 
Chabaupain-2 and P. yoelii) were used as queries to search for templates using the HHpred 
server. The default settings of 3 iterations using the HHsearch MSA method were used to search 
the pdb70 HMM database. The alignment mode used was local alignment.  The search gave a list 
of possible templates (homologous proteins of known experimentally derived 3D structure) 
ordered by E-value. The appropriate template for each target protein was selected based on its 
percentage similarity to the target sequence, high structure resolution and completeness of the 
structure as shown in (Table 3.1). The PDB sequence search was also used; the search takes in 
the protein sequence as a query and displays a list of all 3D structures of similar proteins this 
confirmed results attained by the HHpred search.  
 
FP-2 and its orthologs showed highest similarity to the template (PDB Id: 2O6X) that is the 
cysteine protease of Fasciola hepatica. However the crystallographic structure 2O6X was 
incomplete in the C-terminal of the prodomain and did not fully represent the Plasmodium 
mature domain. A second template was thus used so as to adequately represent the mature 
domain of Plasmodium. The second template used was the crystallographic structure of mature 
domain of FP-2 (PDB Id: 2OUL) or FP-3 (PDB Id: 3BWK) as shown in (Table 3.1). The 
selected templates were then retrieved from the PDB and verified; this was done to analyze the 
quality of the structures been used as this would affect the models attained. Template verification 
was done using PROSA, MetaMQAPII and PROCHECK MQAPs.  
3.2.2 Template-target alignment 
Once the appropriate templates for modeling were selected, alignment of target and template 
sequences was done. Alignments were done using the HHpred server that also created .PIR 
profiles which are an essential alignment format for modeling. The HHpred attained alignments 
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were compared to alignments generated using the PROMALS-3D program (See Chapter 2.3.2) 
and slight hand adjustments were done to achieve optimum alignment of residues which is 
imperative to obtaining good models. Hand adjustment of the template-target alignments is done 
by checking for any misaligned residues and adjusting them accordingly.  
 
3.2.3 Modeling of the protease structure 
Having attained appropriate target to the template alignment, Modeller9v7 was used to calculate 
the homology models. All computations were carried out on a Linux server equipped with eight 
Intel(R) Xeon E5506 processors (2.13 GHZ) with 12 GB of RAM. Modeller automatically 
generated the models once given an input of the alignment in the PIR format, the protein 
coordinate files of the templates and a python script with the appropriate commands. The python 
scripts used in modeling are available in (Appendix B-II). 500 models were generated for each of 
the proteases; incorporating slow refinement to the model building process gave better results. 
Modeller outputs PDB files that contain the coordinates of the models generated. To select the 
best of the 500 built models Modeller is used to calculate the DOPE-Z energy scores of the 
models. A stable protein conformation (native state) is known to be at local and global minimum 
of its surface potential energy; hence the model with lowest energy is selected. A python script 
was run to sort the models by their DOPE-Z energy scores (Appendix B-II), to ease picking out 
models with lowest energy. The models of each target with the lowest energy scores were 
selected for further validation by other programs.  
 
3.2.4 Model validation 
To evaluate the structures of the best models attained, a number of MQAPs were used including 
MetaMQAP, PROCHECK and PROSA. The MQAP evaluated various properties of the structure 
detecting areas of the structure that were inappropriately modeled. Validation made it possible to 
detect mis-oriented side-chains, errors due to misalignment of residues and erroneous main chain 
conformation. The MQAPs were accessed via web servers, the PDB file holding model atom 
coordinates was uploaded and the programs validate models automatically. The evaluated 
models showed that most errors were found to occur in the C-terminal loop region of the 
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prodomain extending to the N-terminal of the mature domain. This allowed for loop refinement 
of specific mis-modeled sections. In some cases however mis-modeled sections was due to 
misalignment of residues hence adjustment were made to alignments and better models built.  
 
3.2.5 Model refinement 
Modeller was used to refine loops by rebuilding selected residues in the model. This was made 
possible by using a python script that specified the residues to be refined (Appendix B-II). 
Modeller input is the python script and the model coordinate file. 100 loop-refined models were 
generated and their DOPE-Z energy scores were computed. Generally an improvement was 
observed in the energy scores attained after refinement. Three models having the lowest energy 
scores were selected and validated using MetaMQAP, PROCHECK and PROSA. The most 
satisfactory model for each of the proteases was selected based on validation results. Having 
attained the most accurate models protein interactions could now be determined. 
 
3.2.6 Interaction analysis 
The PIC webserver was used to calculate the interactions in the generated models. The PDB file 
was uploaded to the server and the interactions are automatically computed. The interactions that 
were observed indicated that; the prodomain is anchored to the active site region primarily by 
hydrophobic interactions within 5 Å of the subsite residues. Numerous hydrogen bonds (having a 
distance of less than 3.5Å between donor and acceptor atoms) were observed between the main-
chains and side chains of prodomain and subsite residues. Ionic/electrostatic interactions within 
less than 6Å of the prodomain and subsite residues were also observed. The prodomain aromatic 
residues were observed to form aromatic interactions with subsite residues. Analysis of 
interactions in each of the models was done and comparison was made to residues of human 
cathepsin-K and cathepsin-L1. 
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3.3 RESULTS AND DISCUSSION 
Results obtained from template selection, target-template alignment, homology modeling and 
domain interactions are discussed here. PyMol (Schorӧdinger, L.L.C. 2010) was used for 
visualization of all models.  
 
3.3.1 Template selection 
Two templates were selected for modeling each of the target proteases. The sequence identity 
and target coverage of the templates is shown in (Table 3.1)  
Table 3.1 Template selection for homology modeling, two templates are selected based on the sequence identify 
to the target protein, resolution and completeness of the structure 
Target sequence Template Organism %similarity Target sequence 
coverage by 
template structure 
Structure 
resolution 
Falcipain-2 2O6X_A Fasciola hepatica 35 161-479 (484) 1.40 
2OUL_A P.falciparum 100 258-481 (484) 2.20 
Falcipain-2B 2O6X_A Fasciola hepatica 35 159-479 (482) 1.40 
2OUL_A P.falciparum 98 256-479 (482) 2.20 
Falcipain-3 2O6X_A Fasciola hepatica 35 168-489 (492) 1.40 
3BWK_A P.falciparum 100 263-489 (492) 2.42 
Vivapain-2 2O6X_A Fasciola hepatica 37 164-484 (487) 1.40 
3BWK_A P.falciparum 67 258-484 (487) 2.42 
P. knowlesi 2O6X_A Fasciola hepatica 38 170-490 (495) 1.40 
2OUL_A P.falciparum 57 268-490 (495) 2.20 
P. berghei 2O6X_A Fasciola hepatica 37 151-467 (470) 1.40 
2OUL_A P.falciparum 52 232-467 (470) 2.20 
P. yoelii 2O6X_A Fasciola hepatica 36 153-469 (472) 1.40 
2OUL_A P.falciparum 49 234-469 (472) 2.20 
Chabaupain-2 2O6X_A Fasciola hepatica 36 151-468 (471) 1.40 
2OUL_A P.falciparum 54 251-468 (471) 2.20 
  
The template (2O6X) which is the crystallographic structure of a cysteine protease (procathepsin 
L1) in Fasciola hepatica (Liver fluke) showed highest similarity to most of the target proteases. 
The 2O6X structure had 30% - 38 % similarity to target proteases and a relatively high resolution 
of 1.40Å (Table 3.1). The template had fairly-good sequence coverage of the target proteases, 
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however it was incomplete in the C-terminal of the prodomain and it did not adequately 
represent the target sequences in the mature domain. FP-2 and its orthologs have unique features: 
a 17 residue insert in the N-terminal of the mature domain and a C-terminal 14-residue insert in 
the mature domain forming an „arm-like‟ projection. These features were absent in the template 
2O6X; hence a second template was selected for modelling to represent the mature domain. The 
crystallographic structures of the mature domains of either FP-2 (2OUL chain A) or FP-3 
(3BWK chain A) were selected as second templates having 41%-100% to the target proteases as 
shown in (Table 3.1).  
 
The three selected templates F. hepatica (2O6X), Falcipain-2 (2OUL) and Falcipain-3(3BWK) 
were retrieved from the PDB and validated. Assessment of the quality of these crystallographic 
structures was essential as it determines the quality of the resultant models. Validation allowed 
us to realise locally stressed regions of template (that is local regions of the template that had 
high energy values). PROCHECK was used to assess the stereochemistry of the templates and 
the results are shown in (Figure 3.1). Template-2O6X was found to have 90.5% residues in most 
favoured region and the remaining 9.5% residues in additional allowed regions. Thus 2O6X was 
a good quality template having no residues in disallowed regions. Template-3BWK was found to 
have 85.6% residues in most favoured regions, 13.4% residues in additional allowed regions, 
0.5% residues in generously allowed regions and 0.5% residues in disallowed regions. There 
were two residues in the disallowed region SER-117 and ASP-119 both occurring in loop regions 
that are away from the active site and would not have effect on the interest region of models 
generated using this template. The template-2OUL was found to have 85.5% residues in most 
favoured regions, 13.4% residues in additional allowed regions and 1.0% residues in generously 
allowed regions. The PROCHECK validation indicated the templates as having acceptable 
stereochemistry; further validation was done using the MetaMQAPII server. The MetaMQAPII 
results are shown in (Figure 3.2), the structures are colored by quality to enhance visualization of 
errors. Blue represents highly scored residues and red poorly scored residues that are likely to be 
erroneous. 
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Figure 3.1 Ramachandran plot of templates F. hepatica-2O6X (top left), Falcipan-3-3BWK (top right) and 
Falcipain-2-2OUL (bottom). Red indicates most sterically favoured region, dark-yellow indicates the additional 
allowed regions, light yellow shows the generously allowed regions and disallowed regions are white. 
The MetaMQAPII validation of templates 2OUL and 3BWK gave GDT-TS scores of 66.286 and 
64.360 respectively (Figure 3.2). This infers that the structures are of good enough quality to be 
used for modelling. The subsite region of these structures occurs between the left and right lobe 
and is mostly blue indicating high scoring residues in this region. The regions that scores poorly 
(shown in yellow - red) are loop regions that occur in the periphery of the structure away from 
the subsite residues of interest to this study. These loop regions can be corrected by refinement in 
the final models that are generated using these templates. The MetaMQAPII validation of 
templates 2O6X shown at the bottom of (Figure 3.2) gave GDT-TS scores of 69.935. This 
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template has good structure quality in its mature domain region as depicted by the deep blue 
colouring. The prodomain structure is also of good quality with an exception of its C-terminal, 
where there is a 1-turn α-helix that is coloured red. This C-terminal helix region however doesn‟t 
directly overlay the active site and may not be employed in the study of protease inhibition. 
Given the GDT-TS scores of 66.286, 64.360 and 69.935 for the templates 2OUL, 3BWK and 
2O6X respectively, it is expected that the models generated using these templates will have 
scores slightly lower than this. 
 
Figure 3.2 MetaMQAPII validation results of templates. Falcipan-3-3BWK (top right), Falcipain-2-2OUL (top 
left) and F. hepatica-2O6X (bottom).  The image is coloured by quality in a spectrum of blue to red where blue is 
highly scored residues and red is poorly scored and erroneous residues. The prodomain and mature domain regions 
of template 2O6X are indicated. Template 2OUL and 3BWK comprise of the mature domain only and the active site 
is situated at the groove between the left and right lobes of the structures. 
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3.3.2 Template-target alignment 
Having selected and validated the appropriate templates for modeling, the sequences of the each 
target and the templates were aligned using the HHpred server. The alignments for each target to 
the templates are available in the (Appendix B-I).  
 
3.3.3 Model building and refinement  
The 3D structures of Plasmodium cysteine proteases (FP-2, FP-2B, FP-3, P.knowlesi, vivapain-2, 
P. berghei, chabaupain-2 and P. yoelii) were built and refined using Modeller. For each of these 
proteases the best model was selected and validated to check its structure quality. Based on this 
assessment of the structure loop refinements were performed to improve the model quality.  
(Table 3.2) gives a detailed summary of the most optimum models attained for each of the 
proteases under study. The summary indicates the model Dope-Z energy scores calculated by 
Modeller and some of the scores of model validation that are discussed in greater detail ahead. 
The 3D structure of the models is shown in figure (Figure 3.3). 
Table 3.2 Summary of the homology models attained of the eight proteases, Dope-Z energy scores calculated by 
Modeller are indicated. GDT-TS validation score by MetaMQAPII server and PROCHECK results are also 
indicated. The RMSD between the model and template 206X is given (as calculated by superimposing the structures 
using PyMol). 
HOMOLOGY MODEL Dope 
Z-score 
MetaMQAPII 
GDT-TS 
RMSD PROCHECK 
Residues in most 
favoured region 
Falcipain-2A.BL00420001.pdb -1.012 64.330 0.723 87.8 
Falcipain-2B.BL00710001.pdb -0.896 68.069 0.549 80.1 
Falcipain-3.BL00280001.pdb -1.018 62.655 0.936 86.6 
P.knowlesi.BL00240001.pdb -0.784 62.227 0.640 88.5 
Vivapain-2.BL00940001.pdb -0.823 63.863 0.891 88.4 
P.berghei.BL00180001.pdb -0.771 64.432 0.719 87.5 
Chabaupain-2.B99990076.pdb -0.596 65.645 0.680 86.2 
P.yoelii.BL00320001.pdb -0.374 60.252     0.686   84.8 
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Figure 3.3 3D structure of the best models attained of (A) FP-2, (B) FP-2B, (C) FP-3, (D) vivapain-2, (E) P. 
knowlesi, (F) P. berghei, (G) chabaupain-2 and (H) P. yoelii. The models are colored in a spectrum of colors 
ranging from blue in the N-Terminal to red in the C-terminal. The N-terminal (blue and light blue) regions represent 
the prodomain, (Green and light green) regions represent the left lobe of the mature domain and the (orange - red) 
regions show the right lobe of the mature domain. 
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Figure 3.3 show the best models generated for FP-2 and its 7 orthologs. The general structure of 
the proteases was analyzed in accordance to the clusters formed in the phylogenetic tree (Figure 
2.5). FP2 (Figure 3.3 A) and FP2B (Figure 3.3 B) seem to have a fairly similar topology in the 
mature domain. However the C-terminal section of the prodomain seems to differ. The α-helix in 
this C-terminal region is shorter in FP2B that FP2. The structure of FP-3(Figure 3.3C) differs 
from closely related FP2 and FP2B structures in the mature domain. FP3 is lacking in a β-sheet 
at the C-terminal of the mature domain that is present in FP2 and FP2B. FP3 also has a helical 
structure in the left lobe of the mature domain that is not present in FP2 and FP-2B. FP3 
structure in the C-terminal of the prodomain is also different from that of FP2 and FP2B this can 
be attributed to the sequence dissimilarity among these sequences. 
 
The structures of Vivapain-2 (Figure 3.3 D) and P. knowlesi (Figure 3.3 E) were also compared 
as they seem to be more closely related according to the phylogenetic analysis (Figure 2.5). The 
structure of P. knowlesi has a β-sheet in the C-terminal of the mature domain that is lacking in 
Vivapain-2. Vivapain-2 also has an additional helical structure in the left lobe of the mature 
domain that is similar to that in FP-3. The C-terminal of the prodomain of Vivapain-2 has a 
helical structure that is lacking in P. knowlesi. This C-terminal section in P. knowlesi has entirely 
loop structure 
 
The structures of the three murine proteases P. berghei (Figure 3.3 F), chaubaupain-2 (Figure 3.3 
G) and P. yoelii (Figure 3.3 H) were compared. The three protease structures were generally 
similar in the mature domain. However the structure of P. yoelii was lacking in a β-sheet in the 
C-terminal of the mature domain that was present in chabaupain-2 and P. berghei. The C-
terminal of the prodomain in P. berghei had an additional helical structure that is lacking in 
chaubapain-2 and P. yoelii. In place of this additional helical structure chabaupain-2 had a β-
sheet that was absent in P. yoelii. The structure of P. yoelii in this region is purely comprised of 
loop structure. The structural differences in the C-terminal of the prodomain of these proteases 
can be attributed to the varying sequences in this region. This region was also difficult to model 
due to lack of template coverage hence most of the modeling was done by loop building.  
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3.3.4 Model validation and interaction analysis 
3.3.4.1 FP-2 
The best attained 3D model of FP-2 is as shown in part (A) of (Figure 3.3). This model is 
generated based on the templates 2O6X and 2OUL. The initial model before loop refinement had 
a DOPE-Z energy score of -0.834 that showed considerable improvement after loop refinement 
giving an energy score of -1.012. The optimum DOPE-Z score for a structure in its native state is 
below-1. The model was then validated using PROSA, MetaMQAPII and PROCHECK to assess 
its structure quality. PROSA validation gave a surface energy Z-score of -7.42 this was plotted 
along-side Z-scores of all the experimentally derived structures in the PDB (Figure 3.4). The plot 
showed that the FP-2 model structure is within the desired range of native conformations.  
 
Figure 3.4 Validation of FP-2 structure part (A) is the PROSA global energy plot FP-2 structure is plotted as the 
black dot other PDB structures are in blue and light blue dots. Part (B) is the PROSA local plot in a 10 and 40 
residue window. Part (C) the PROCHECK validation ramachandran plot and part (D) is the MetaMQAPII structure 
validation colored by quality in a spectrum of blue (good) to red (bad). 
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PROSA local model quality plot shows the energy per residue. Most residues in the model 
seemed to be appropriately modeled having low energy scores (below the zero line), with an 
exception of one major peak observed (Figure 3.4 B). The peak coincided with the N-terminal of 
the mature domain where a 17 residue insert unique to Plasmodium occurs. This region was 
difficult to model as it was absent in one of the templates (2O6X) used for modelling; hence the 
predicted structure in this region may not be fully accurate. However the N-terminal of the 
mature domain does not lie in our area of interest in the structure and will not affect observation 
of the desired interactions in the structure (Figure 3.5). MetaMQAPII validation gave a GDT-TS 
score of 64.330 which is a fairly good structure. MetaMQAPII validation reflected the 
problematic region of this structure (colored red) as the N-terminal of the mature domain this 
coincided with the PROSA results. Loop refinement seemed to improve this region of the 
structure though energy scores of residues in this region remained high (Figure 3.4D). 
PROCHECK verification gave a ramachandran plot with 87.8% of the residue in the most 
favored region. Judging from the structure in the active site region and the prodomain section 
overlaying it the structure was considered fit for use in structural analysis. 
 
The PIC enabled calculation of the interactions between the prodomain and mature domain 
residues. α-3 helix affixes the prodomain to the active site, residues 213-236 in this prodomain 
region were found to be in interaction with the subsites (Figure 3.5). The subsites S1 and S1' 
(located in the anterior section of the substrate binding pocket) were occupied by prodomain 
residues; Arg-213 (S1), Phe-214 (S1'), Tyr-219 (S1'), Phe-222 (S1'), Lys-223 (S1'), Lys-225 (S1) 
and Tyr-226 (S1). Several hydrogen bonds, hydrophobic and aromatic contacts occur between 
these prodomain residues and residues in subsite S1 and S1'. Each of these residue interactions 
were analyzed as depicted in part A of (Figure 3.5). Arg-213 a polar basic prodomain residue 
forms an ionic interaction with Asp-278 (S1). The side-chain NH2 group of Arg-213 also forms 
a hydrogen bond to the main-chain carbonyl oxygen in Trp-449 (S1'). Three aromatic prodomain 
residues Phe-214, Phe-222 and Tyr-226 form aromatic interactions with Trp-449 (S1'). This 
aromatic stacking anchors the prodomain to the subsite S1'. Phe-214 also forms hydrophobic 
interactions with non-polar residues Ala-400 and Trp-453 in subsite S1'. Tyr-219 and Phe-222 
non-polar prodomain residues form hydrophobic interactions to Val-395 (S1'). Phe-222 is also in 
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hydrophobic interaction with and Ala-400 (S1'). The Lys-223 and Lys-225 polar basic 
prodomain residues form an ionic bonds with Asp-413 (S1') and Asp-352(S1) respectively.  
 
Figure 3.5 Prodomain interactions to FP-2 subsites; the top diagram shows in purple the prodomain region (213-
236) interacting with subsite residues (red indicates the active site). A- represents the prodomain residues (purple 
sticks) interacting with residues in subsite S1 and S1' (green sticks) and B represents interactions in subsite S2 and 
S3. Prodomain residues are labeled. 
The subsite S2 and S3 are occupied by prodomain residues: Ser-228 (S2), Leu-229 (S3), Ser-231 
(S2) and Lys-236 (S3) (Part B Figure 3.5). The main-chain amide nitrogen atoms of residues 
Ser-228 and Ser-231 form hydrogen bonds to the carbonyl oxygen of residues Leu-415 (S2) and 
Asn-416 (S2) respectively. This anchors the prodomain to subsite S2. The side-chain of Ser-228 
was also found at a distance of 3.96Å to the catalytic sulphur of active site Cys-285, there is 
likely hydrogen bonding between the two residues. Leu-229 a polar prodomain residue forms 
hydrophobic contact to Tyr-321(S3) and Leu-327 (S3). A salt bridge occurs between Lys-236 a 
polar basic prodomain residue and Asp-477 (S2). The side-chain of Lys-236 also forms a 
hydrogen bond to the side chain of Asn-329 (S3).  
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3.3.4.2 FP-2B 
The model of FP-2B is as shown in part B of (Figure 3.3); the model was attained based on 
templates 2O6X and 2OUL with a DOPE Z score of -0.896. The FP-2B model was validated 
using PROSA, VERIFY3D and MetaMQAPII (Figure 3.6). PROSA gave a surface energy score 
of -6.42, that in a plot with other structures from the PDB was shown to lie in a conformationaly 
acceptable region. PROSA local model quality plot showed a prominent peak region indicative 
of an inacuracy in the structure (Figure 3.6 B). The region corresponds to the C-terminal of the 
prodomain extending to the adjacent N-terminal of the mature domain in the structure. This 
region as discussed earlier was problematic to model due to lack of template coverage hence the 
structure was predicted by loop building and may not have been entirely accurate. This region is 
however not of interest to this study. MetaMQAPII validation gave a GDT-TS score of 68.069.  
 
Figure 3.6 Validation of FP-2B structure: part (A) is the PROSA global energy plot FP-2 structure is plotted as 
the black dot other PDB structures are in blue and light blue dots. Part (B) is the PROSA local plot in a 10 and 40 
residue window. Part (C) the PROCHECK validation ramachandran plot and part (D) is the MetaMQAPII structure 
validation colored by quality in a spectrum of blue (good) to red (bad). 
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PROCHECK analysis gave a plot showing 80.1% of the residues were in allowed regions. 
However 2.4% of the model residues were found in dissallowed regions these residues occur in 
the C-termainal of the prodomain and the N-terminal of the mature domain in the structure. 
Validation inferred that the structure quality in the subsites and the overlaying prodomain was 
good enough for use in interaction analysis.  
 
Figure 3.7 Prodomain interactions to FP-2B subsites; the top diagram shows in purple the prodomain region 
(210-229) interacting with subsite residues (red indicates the active site). A- represents the prodomain residues 
(purple sticks) interacting with residues in subsite S1 and S1' (green sticks) and B represents interactions in subsite 
S2 and S3. Prodomain residues are labeled. 
Prodomain residues between positions 210-229 were found to be interaction with the subsites 
(Figure 3.7). Subsite S1 and S1' were occupied by prodomain residues: Asn-210 (S1'), Arg-211 
(S1), Phe-212 (S1'), Try-217 (S1'), Phe-220 (S1'), Lys-221 (S1'), Lys-223 (S1), Tyr-224 (S1), 
Leu-225 (S1') and Thr-226 (S1). Each of these residue contacts to S1 and S1' were analyzed 
(Figure 3.7). The side-chain of prodomain residue Asn-210 forms a hydrogen-bond to the 
carbonyl oxygen of Pro-398 (S1'). Arg-211 a basic polar prodomain residue forms an ionic bond 
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with Asp-276 (S1). Three aromatic residues of the prodomain Phe-212, Phe-220 and Tyr-224 are 
in aromatic interaction to Trp-447(S1'). These aromatic side-chains residues adequately obstruct 
subsite S1' and are supported by additional hydrophobic interactions. The aromatic residues Phe-
212 and Phe-220 form hydrophobic contacts with Trp-451 (S1') and Val-393 (S1') respectively. 
A non-polar prodomain residue Tyr-217 forms hydrophobic interactions with Val-393 (S1') and 
Pro-398 (S1'). The side-chain of Try-217 also forms a hydrogen bond to Asp-411 (S1').  
 
The prodomain interacts via salt bridges to the S1 subsite causing inhibition. Basic polar 
prodomain residue Lys-221 is forms an ionic bond with Asp-411 (S1) and Glu-412 (S2). Another 
basic polar prodomain residue Lys-223 forms a salt bridge with residue Glu-350 (S1). The side-
chain of Tyr-224 is in hydrogen bonding with the carbonyl oxygen of Lys-278 (S1). The non-
polar prodomain residues Leu-225 and Thr-226 are in hydrophobic contact with Gly-281 (S1) 
and Val-393 (S1') respectively. Hence the Subsite S1 and S1' are effectively obstructed. 
 
Three prodomain residues Leu-227, Arg-228 and Ser-229 occupy the subsite S2 and S3 subsites 
(Part B Figure 3.7). Leu-227 forms hydrophobic interactions with Leu-413(S2), Ala-416(S2), 
Leu-325 (S3) and Ile (S3). A salt bridge is formed between prodomain polar basic residue Arg-
228 and Glu-412 (S2). The side-chain of prodomain residue Ser-229 is in hydrogen bonding with 
Asp-475(S2). These residues occupy the groove which substrates follow to access the catalytic 
residues, by forming contacts to the subsites S2 and S3 hence inhibiting the protease. 
 
3.3.4.3 FP-3 
The model of FP-3 is attained using template 2O6X and 3BWK (part C of Figure 3.3). PROSA 
validation of the model gave a surface energy score -7.11 that was plotted with other structures 
in the PDB and found to be conformational acceptable (Figure 3.8 B). PROSA local model 
quality plot showed that the structure was acceptable with most residues having low energy 
scores. MetaMQAPII validation gave a GDT-TS score of 62.655 and depicted some high energy 
residues in the N-terminal of the mature domain. This inaccuracy in the model was as a result of 
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the 3BWK template used in modelling that also showed high residues in the N-terminal of the 
mature domain (Figure 3.2 A). PROCHECK analysis gave a ramachandran plot placing 86.6% 
residues in the most favored regions. FP-3 model structure quality was generally acceptable with 
emphasis been placed on the active site region and the prodomain region overlapping it. 
 
Figure 3.8 Validation of FP-3 structure: part (A) is the PROSA global energy plot FP-2 structure is plotted as the 
black dot other PDB structures are in blue and light blue dots. Part (B) is the PROSA local plot in a 10 and 40 
residue window. Part (C) the PROCHECK validation ramachandran plot and part (D) is the MetaMQAPII structure 
validation colored by quality in a spectrum of blue (good) to red (bad). 
 
Interactions between the prodomain and the subsite residues were analysed, residues 218-235 of 
the prodomain were in contact with the active site region (Figure 3.9). Subsite S1 and S1' were 
found to be occupied by prodomain residues; Asn-218 (S1'), Lys-219 (S1), Phe-220 (S1'), Phe-
228 (S1'), Lys-231 (S1), Tyr-232 (S1) and Leu-233 (S1'). The individual interactions of these 
prodomain residues with the S1 and S1' subsites were analysed. The side-chain of prodomain 
residue Asn-218 forms a hydrogen bond with Asp-460 (S1'). A salt bridge is formed between 
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prodomain residue Lys-219 and Asp-286 (S1). The main-chain carbonyl oxygen of Lys-219 also 
forms a hydrogen bonding with Asp-460 (S1'). Three aromatic prodomain residues Phe-220, 
Phe-228 and Tyr-232 are in aromatic contact with Trp-457 occupying subsite S1'. Phe-220 and 
Phe-228 also form hydrophobic interactions with Trp-461 (S1') and Ala-408 (S1') respectively. 
The side-chain of prodomain residue Lys-231 is in hydrogen bonding with Tyr-332 (S1). Non-
polar prodomain residueTyr-232 forms hydrophobic interactions to Ala-288 and Leu-289 in 
subsite S1. Leu-233 forms hydrophobic interactions with Trp-457 (S1') and Ala-403 (S1').  
 
Figure 3.9 Prodomain interactions to FP-3 subsites; the top diagram shows in purple the prodomain region (218-
235) interacting with subsite residues (red indicates the active site). A- represents the prodomain residues (purple 
sticks) interacting with residues in subsite S1 and S1' (green sticks) and B represents interactions in subsite S2 and 
S3. Prodomain residues are labeled. 
The prodomain residues Asn-234 and Leu-235 were found to occupy subsite S2 and S3 (Figure 
3.9). Asn-234 forms main-chain hydrogen bonding with the carbonyl oxygen in Asn-424 (S3). 
The non-polar prodomain residue Leu-235 forms hydrophobic interactions with Trp-294 (S2), 
Ile-336 (S2) and Ala-426 (S3) 
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3.3.4.4 P. knowlesi 
This structure was modelled using template 2O6X and 2OUL. PROSA structure validation gave 
a global surface energy score of -6.59, which in a global plot with energy scores of other 
structures in the PDB showed that the model is in the desired range of structure conformation. 
PROSA local model quality assessment reveals two peaks at the C-terminus of both the mature 
domain and the prodomain. A closer look at the residues in this region showed there was low 
similarity in aligned residues between target and template hence making it error prone and it is 
likely that the C-backbone and the side-chains of these residues were wrongly predicted. 
MetaMQAPII validation presented a faulty α-2 helix region in the prodomain this is attributed to 
low similarity of target to template sequence in this region. MetaMQAPII gave a GDT-TS score 
of 62.227. PROCHECK analysis showed 88.5%.of the residues were in the most favored regions. 
The rest of the model was of good quality and acceptable for use in interaction analysis 
 
Figure 3.10 Validation of P. knowlesi structure: part (A) is the PROSA global energy plot FP-2 structure is 
plotted as the black dot other PDB structures are in blue and light blue dots. Part (B) is the PROSA local plot in a 10 
and 40 residue window. Part (C) the PROCHECK validation ramachandran plot and part (D) is the MetaMQAPII 
structure validation colored by quality in a spectrum of blue (good) to red (bad). 
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Interaction analysis of P. Knowlesi showed that prodomain residues 220-239 lie in the active site 
region (Figure 3.11). The subsites S1 and S1' were occupied by prodomain residues; Asn-220 
(S1'), Arg-221 (S1), Phe-222 (S1'), Phe-227 (S1'), Phe-230 (S1'), Lys-233 (S1) and Tyr-334 (S1). 
Each of these residues was analyzed to view interactions with the subsites. The side-chain of 
prodomain residue Asn-220 is in hydrogen bonding with the main-chain carboxylic oxygen of 
Tyr-410 (S1'). Three aromatic residues Phe-222, Phe-230 and Tyr-234 form aromatic 
interactions with Trp-458 (S1). Phe-222 and Phe-227 are also in hydrophobic interaction with 
Trp-462 and Ala-404 respectively. These aromatic and hydrophobic interactions occupy subsite 
S1'. Subsite S1 is occupied by prodomain residue Lys-233 that is in hydrogen bonding with Asn-
290 (S1). A basic polar prodomain residue Arg-221 forms an ionic bond with Asp-289 (S1). 
 
Figure 3.11 Prodomain interactions to P. knowlesi subsites; the top diagram shows in purple the prodomain 
region (220-239) interacting with subsite residues (red indicates the active site). A- represents the prodomain 
residues (purple sticks) interacting with residues in subsite S1 and S1' (green sticks) and B represents interactions in 
subsite S2 and S3. Prodomain residues are labeled. 
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The prodomain residues Leu-235, Thr-236, Leu-237 and Lys-238 were found to occupy the 
subsite S2 and S3 (Figure 3.11). Non-polar prodomain residues Leu-235 and Leu-237 form 
hydrophobic interactions with Ala-404 (S2) and Ile-422 (S2) respectively. Thr-236 forms main-
chain hydrogen bonding with Asn-425 (S2) .The side-chain of Lys-238 is at a distance of 3.64Å 
from the catalytic sulphur of Cys-294 there is likely hydrogen bonding. The main-chain of Lys-
238 is also in hydrogen bonding with the main-chain carboxylic oxygen of Pro-424 (S2) 
 
3.3.4.5 Vivapain-2 
The model of vivapain-2 was attained based on template 2O6X and 3BWK. PROSA structure 
validation gave a global surface energy score of -6.78 that in a global plot showed that the model 
lied in the desired range of structure conformation (Figure 3.12 B). 
 
Figure 3.12 Validation of vivapain-2 structure: part (A) is the PROSA global energy plot FP-2 structure is plotted 
as the black dot other PDB structures are in blue and light blue dots. Part (B) is the PROSA local plot in a 10 and 40 
residue window. Part (C) the PROCHECK validation ramachandran plot and part (D) is the MetaMQAPII structure 
validation colored by quality in a spectrum of blue (good) to red (bad). 
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PROSA local model quality assessment revealed that most residues in the structure had minimal 
energy. However a prominent peak was observed at the C-terminus of the prodomain. This 
coincided with MetaMQAPII validation that showed high energy scores at the C-terminal and α-
2 helix of the prodomain. The target residues in this region had low similarity in to those of the 
template hence it is likely that the C-backbone and the side-chains of these residues were not 
accurately modelled. MetaMQAPII validation gave a GDT-TS score of 63.869. PROCHECK 
analysis showed 88.4% of the residues were in the most favored regions. The rest of the model 
was of good quality and acceptable for use in interaction analysis.  
 
 
Figure 3.13 Prodomain interactions to vivapain-2 subsites; the top diagram shows in purple the prodomain 
region (214-231) interacting with subsite residues (red indicates the active site). A-Represents the prodomain 
residues (purple sticks) interacting with residues in subsites (green sticks). Prodomain residues are labeled. 
Interaction analysis showed that prodomain residues (214-231) were in interaction with the 
active site (Figure 3.13). The prodomain residues in contact with subsite S1 and S1' include: 
Asn-214 (S1'), Glu-215 (S1), Phe-216 (S1'), Phe-221(S1'), Phe-224 (S1'), and Tyr-228 (S1'). The 
individual interactions of these residues were observed.  The side-chains of prodomain residues 
Asn-214 and Glu-215 forms hydrogen bonds to the main-chain carboxyl oxygen atoms of Ala-
401 (S1') and Trp-452 (S1') respectively. Glu-215 is also in hydrogen bonding with the side-
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chain of Asp-281 (S1). Three aromatic prodomain residues Phe-216, Phe-224 and Try-288 form 
aromatic interactions with Trp-452 anchoring the prodomain to the subsite S1'. Phe-216 was also 
found to be in hydrophobic interactions with Trp-456 (S1'). Non-polar prodomain residues Phe-
221 and Phe-224 both form hydrophobic interactions with Val-398 and Ala-403 in subsite (S1). 
The prodomain residues Lys-225 (S2), Thr-230 and Leu-231 were found to occupy the subsite 
S2 and S3. A salt bridge is formed between Lys-225 and Glu-418(S2). Thr-230 is in side-chain 
hydrogen bond with the catalytic sulphur Cys-288. Leu-231 is in hydrophobic interaction with 
Phe-330 (S3) (Figure 3.13) 
 
3.3.4.6 P. berghei 
The model of P. berghei is attained using template 2O6X and 2OUL. PROSA validation gave a 
surface energy score -7.82 that was plotted with other structures in the PDB and found to be 
conformational acceptable (Figure 3.14 B). PROSA local model quality plot showed that the 
structure was good most residues having low energy scores. MetaMQAPII validation gave a 
GDT-TS score of 64.432 and depicted some high energy scoring residues in the of α-2 helix of 
the prodomain. A closer look at the sequence alignment in this region showed low similarity 
between template and target. PROCHECK analysis gave a ramachandran plot placing 87.5% 
residues in the most favored regions. This model structure was very well modelled and the 
validation showed good structure quality acceptable for interaction analysis (Figure 3.14 D) 
 
The prodomain residues (200-219) were observed to interact with the subsites (Figure 3.15). 
Subsites S1 and S1' were occupied by prodomain residues; Asn-200 (S1'), Phe-202 (S1'),   His-
207 (S1'), Phe-210 (S1'), Lys-211 (S1'), and Try-214 (S1). The individual interactions of these 
prodomain residues with the S1 and S1' subsites were analysed. The side-chain of Asn-200 
interacts via hydrogen bonds to carboxylic oxygen in the main-chain of Glu-287 (S1'). The 
aromatic prodomain residues Phe-202, Phe-210 and Tyr-214 form aromatic interactions to Typ-
436 (S1'). The three prodomain residues Phe 202, Phe-210 and Tyr-214 were also in 
hydrophobic interaction with Trp-440, Val-382 and Trp-440 in subsite S1' respectively. Two salt 
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bridges occur between prodomain residues His-207 and Lys-211 with subsite residues Asp-
384(S1') and Asp-400 (S2). 
 
Figure 3.14 Validation of P. berghei model: part (A) is the PROSA global energy plot FP-2 structure is plotted as 
the black dot other PDB structures are in blue and light blue dots. Part (B) is the PROSA local plot in a 10 and 40 
residue window. Part (C) the PROCHECK validation ramachandran plot and part (D) is the MetaMQAPII structure 
validation colored by quality in a spectrum of blue (good) to red (bad). 
 
S2 and S3 were occupied by prodomain residues Leu-215, Asn-217 and Leu-219. Leu-215 forms 
hydrophobic interactions with Ala-250 (S3) (Figure 3.15). Asn-217 is in main-chain hydrogen 
bonding with Gly-313 (S3). The side-chain of Asn-217 is also at a distance of 3.77Å to the 
catalytic sulphur of Cys-272 and is likely in hydrogen bonding. Leu-219 is in hydrophobic 
interaction with Phe-401 and Ala-402 (S2) 
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Figure 3.15 Prodomain interactions to P. berghei subsites; the top diagram shows in purple the prodomain region 
(200-219) interacting with subsite residues (red indicates the active site). A- Represents the prodomain residues 
(purple sticks) interacting with residues in subsites (green sticks). Prodomain residues are labeled. 
 
3.3.4.7 Chabaupain-2 
The model of chabaupain-2 was modelled based on templates 2O6X and 2OUL. PROSA 
validation gave a surface energy score -7.19 that was plotted with other structures in the PDB 
and found to be conformational acceptable (Figure 3.16 B). PROSA local model quality plot 
showed that the structure was good most residues having low energy scores with an exception of 
the C-terminal of the prodomain. MetaMQAPII validation gave a GDT-TS score of 65.645 and 
depicted some high energy residues in the C-terminal of the prodomain and in the α-2 helix. 
PROCHECK analysis gave a ramachandran plot placing 86.2% residues in the most favored 
regions. This model structure quality was very well modelled the validation showed good 
structure quality and was acceptable for interaction analysis 
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Figure 3.16 Validation of chabaupain-2 model: part (A) is the PROSA global energy plot FP-2 structure is plotted 
as the black dot other PDB structures are in blue and light blue dots. Part (B) is the PROSA local plot in a 10 and 40 
residue window. Part (C) the PROCHECK validation ramachandran plot and part (D) is the MetaMQAPII structure 
validation colored by quality in a spectrum of blue (good) to red (bad). 
 
Interactions were evaluated residue (201-220) of the prodomain were found to be in interaction 
with the active site region of the protease. The S1 and S1' were occupied by the prodomain 
residues: Asn-201 (S1'), Pro-202 (S1'), Phe-203 (S1'), Phe-211 (S1') and Tyr-215 (S1). The 
interactions of each residue were defined. The side-chain of Asn-201 formed a hydrogen bond to 
the main-chain carboxylic oxygen of Glu-238 S1'). Pro-202 forms a hydrophobic interaction with 
Ala-440 in (S1'). Three aromatic prodomain residues Phe-203, Phe-211 and Try-215 form 
aromatic interactions to Trp-437. Phe-203 is also found in hydrophobic interaction with Trp-441. 
The side-chain of Try-215 forms a hydrogen bond to the main-chain of Lys-268 (S1). 
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Figure 3.17 Prodomain interactions to chabaupain-2 subsites; the top diagram shows in purple the prodomain 
region (201-220) interacting with subsite residues (red indicates the active site). A- Represents the prodomain 
residues (purple sticks) interacting with residues in subsites (green sticks). Prodomain residues are labeled. 
 
The residues of the prodomain in contact with S2 and S3 include Leu-216, Asn-217, Lys-219 
and Leu-220 (Figure 3.17). Non-polar prodomain residues Leu-216 and Leu-220 form 
hydrophobic interactions with Ala-383 and Phe-404 respectively in subsite S2. The side-chain of 
Asn-217 is in hydrogen bonding with the carboxylic oxygen of Glu-312 (S3). Lys-219 is in 
main-chain hydrogen bonding with Ala-403 (S2) 
 
3.3.4.8 P. yoelii 
The model of P. yoelii was modelled based on templates 2O6X and 2OUL. PROSA validation 
gave a surface energy score -7.09 that was plotted with other structures in the PDB and found to 
be conformational acceptable (Figure 3.18 B). PROSA local model quality plot showed that the 
structure was good most residues having low energy scores with an exception of the C-terminal 
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of the prodomain. MetaMQAPII validation gave a GDT-TS score of 60.252 and depicted some 
high energy residues in the C-terminal of the prodomain. This C-terminus of the prodomain was 
missing in the template used hence it is likely that the predictions in this region was erroneous. 
PROCHECK analysis gave a ramachandran plot placing 84.8% in the most favored regions. 
However 2.4% residues were found in disallowed regions a close look at this residues shows 
they occurs from residue 77-89 which is the C-terminal of the prodomain. This model structure 
quality was very well modelled the validation showed good structure quality and was acceptable 
for interaction analysis 
 
 
Figure 3.18 Validation of P. Yoelii model: part (A) is the PROSA global energy plot FP-2 structure is plotted as the 
black dot other PDB structures are in blue and light blue dots. Part (B) is the PROSA local plot in a 10 and 40 
residue window. Part (C) the PROCHECK validation ramachandran plot and part (D) is the MetaMQAPII structure 
validation colored by quality in a spectrum of blue (good) to red (bad). 
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Interaction analysis prodomain region (202-221) interacts with the subsites (Figure 3.19). S1 and 
S1' were occupied by prodomain residues Asn-202 (S1'), Phe-204 (S1'), His-209 (S1'), Phe-212 
(S1'), Tyr-216 (S1'). The side-chain of Asn-202 forms a hydrogen bond to the main-chain of Glu-
389 (S1'). Three prodomain residues; Phe-204, Phe-212 and Tyr-216 form aromatic interactions 
to Trp-438 in subsite S1'. Phe-204 and Phe-212 are also found in hydrophobic contact to Trp-448 
and Val-384 in subsite S1'.  
The prodomain residues Asn-218, Asn-219, Leu-221 occupy S2 and S3 (Figure 3.19). The side-
chains of prodomain residues Asn-218 and Asn-219 form hydrogen bonds to the carboxylic 
oxygen of Gly-315 (S3). Asn-218 also forms main-chain hydrogen bonding to Asn-405 (S2). 
The side chain of Asn-218 is at a distance of 3.66Å to the side-chain of catalytic Cys-274. 
Hydrophobic prodomain residue Leu-221 forms hydrophobic interactions to Ala-404, Val-462 
and Val-464 in the S2 subsite. 
 
Figure 3.19 Prodomain interactions to P. yoelii subsites; the top diagram shows in purple the prodomain region 
(202-221) interacting with subsite residues (red indicates the active site). A- Represents the prodomain residues 
(purple sticks) interacting with residues in subsites (green sticks). Prodomain residues are labeled. 
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3.3.5 Summary of interactions 
The prodomain residues responsible for inhibition are summarized in (Table 3.3). Showing the 
residues inhibiting subsites S1, S1', S2 and S3. The corresponding residues in human proteases: 
cathepsin-L1 and cathepsin-H are indicated.  
Table 3.3 Summary of prodomain residues inhibiting the various subsites. Corresponding human protease 
residues are grey highlighted. Darker shade of grey points out major substitutions observed in the human proteases 
 
The prodomain segment in interaction with the subsites spans from residue 212 to 231 (FP-2 
numbering). At the beginning of this segment, there are three conserved residues (212-214) Asn, 
Arg and Phe (NRF) observed to occupy and hence inhibit the S1' in the proteases (Table 3.3). 
After which an essential aromatic Try/Phe/His residue (219) is observed in most of the proteases 
to inhibit subsite S1' via hydrophobic interactions. This aromatic residue is replaced by serine in 
human proteases. Next is a sequence of interacting residues (222-227) FKKYL that are essential 
in binding to the S1 and S1' subsite via aromatic, hydrophobic, ionic and hydrogen bonds. The 
subsequent four residues (228-231) NLKS, obstruct the S2 and S3 subsites via hydrophobic and 
hydrogen bonding.  
 
Protease Subsite S1 and  S1'  Subsite S2 and S3 
FP-2  R-213 F-214 Y-219 F-222 K-223 K-225 Y-226   S-228 L-229  S-231 
FP-2B N-210 R-211 F-212 Y-217 F-220 K-221 K-223 Y-224 L-225  T-226 L-227 R-228 S-229 
FP-3 N-218 K-219 F-220  F-228  K-231 Y-232 L-233  N-234 L-235   
Vivapain-2 N-214 Q-215 F-216 F-221 F-224 K-225  Y-228   T-230 L-231   
P. Knowlesi N-220 R-221 F-222 F-227 F-230  K-233 Y-334 L-235  T-236 L-237 K-238  
P. berghei N-200  F-202 H-207 F-210 K-211  Y-214 L-215   N-217  L-219 
Chabaupain-2 N-201 P-202 F-203  F-211   Y-215 L-216  N-217  K-219  
P. Yoelii  N-202  F-204 H-209 F-212   Y-216   N-218 N-219  L-221 
Cathepsin –L1 N-78 A-79 F-80 S-85 F-88 R-89 V-91 M-92 N-93  G-94 F-95 Q-96 N-97 
Cathepsin-K N-76 H-77 L-78 S-83 V-86 V-87 K-89 M-90 T-91  G-92 L-93 K-94 V-95 
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Having identified these residues and their fostering interactions, it was necessary to pick out a 
short contiguous section that contains most of the interacting residues. Hence we propose the 
most suitable prodomain peptide responsible for inhibition of FP-2, FP-2B, FP-3, vivapain-2 and 
P.knowlesi is residues 222-232 (FP-2 numbering). The sequence of the peptide in FP-2 is 
FKNKYLSLRS; it is a ten residue continuous section of the prodomain inhibiting all four 
subsites. The peptide sequence varies slightly in each of the proteases;  
 FP-2 (FKNKYLSLRS) 
 FP-2B (FKSKYLTLRS) 
 FP-3 (FRSKYLNLKT) 
 Vivapain-2- (FKKKYLTLKS)  
 P. ovale (FEKKYLTLKT).  
We also propose a prodomain peptide (residues 222-233) responsible for inhibition of the 3 
murine Plasmodium species proteases. The peptide sequence varies slightly in each species: 
 P. berghei (FKMKYLNNKLK) 
 Chabaupain-2 (FKMRYLNSKLS)  
 P. yoelii (FKMKYLNNKLK) 
 
3.4 CONCLUSION AND FUTURE WORK 
Prodomains have been shown to have selective inhibition towards their parent enzymes (Cygler 
et al. 1997) and this project aimed to design short peptide that could mimic this inhibition. 
Having attained peptide sequences that are likely to have selective inhibition of the target 
proteases. The next step is to test the binding affinity and specificity of these peptides. This 
would be made possible by synthesis of these peptides in the lab. Assays can then be carried out 
to test the inhibition effect of prodomain peptides on intraerythrocytic Plasmodium parasites in 
culture. Hemoglobin degradation of the peptide treated Plasmodium parasites can be monitored 
to verify inhibition of cysteine protease activity. An alternative approach would be to amplify the 
genes of the cysteine proteases and express recombinant proteases in E. coli. In vitro assays can 
then be conducted to test the ability of the peptides to inhibit substrate hydrolysis of the 
proteases. 
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A number of peptide based inhibitors against FP-2 have been identified (Ettari et al. 2007). 
However the practicality of using peptide inhibitors is limited by many factors including peptide 
ability to transverse cell membranes, peptide susceptibility to proteolysis and orientation of 
peptide binding in the active site. This factors need to be put into consideration in 
peptidomimetic drug design. This is achieved by replacement of natural residues with unnatural 
amino acids or incorporating a non-peptidic scaffold to the peptide sequence to increase potency 
and stability against proteolysis as well as enhance oral bioavailability. Peptidomimetic 
inhibitors of FP-2 have been designed based on a 1,4-benzodiazepine (BDZ) scaffold, which 
mimics the fragment D-Ser-Gly, that binds reversibly to the active site inhibiting the enzyme 
(Micale et al. 2006). BDZs are in a class of drugs known to have good oral bioavailability and be 
well tolerated. The peptidomimetic was potent and selective against FP-2 and FP-2B having 
significant antimalarial activity. Hence it is promising that the peptides identified in this study 
can be developed into antimalarial peptidomimetic. 
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II. PROMALS-3D alignment used as dataset for phylogenetic analysis 
 
Figure A-2. Alignment of Plasmodium and human species used in generating the neighbour joining tree. Alignment 
was done using PROMALS3D program.  Contiguous un-gapped sections of the full length alignment in (Appendix 
A-I) were used as dataset for phylogenetics  
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III. Comparison of prodomain alignments generated using the various multiple 
sequence alignment programs  
 
Figure A-3. Comparison of the prodomain alignment by the four alignment programs PROMALS 3D, MUSCLE, 
MAFFT and T-COFFEE. PROMALS3D gives the best alignment the other alignment programs seem to have 
inaccuracy (highlighted in red dashes). MUSCLE and MAFFT programs misalign the C-terminal region. T-
COFFEE seems to put in unnecessary gaps in the C-terminal region of the alignment. 
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IV. HHpred structural alignment of FP-2 and the crystallographic structure of 
cysteine protease in Fasciola hepatica (2O6X).  
The HHpred alignment has columns (Q ss_pred and T ss_pred) for the structure prediction of 
FP-2 and 2O6X respectively, and a column for the actual structure (T ss_dssp). where the 
three columns are at a consensus it indicates accuracy of alignment. This guide was used to 
hand adjust alignments. 
 
Figure A-4 Structural alignment of FP-2 and 2O6X; Q ss_pred and T ss_pred are predicted secondary structure for 
the FP-2 and 2O6X, T ss_dssp is the actual secondary structure of 2O6X. Upper and lowercase amino acids show 
high-60% and low-40% conservation. Symbols rate the alignment as: '|' very good, '+' good, '.' neutral, '-' bad and '=' 
very bad. 
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APPENDIX B: HOMOLOGY MODELLING 
I. Template-target alignments for homology modelling.  
 
 
Figure B-1 The alignment for FP-2 with templates 2O6X and 2OUL  
 
 
Figure B-2 The alignment for FP-2B with templates 2O6X and 2OUL  
 
 
Figure B-3 The alignment for FP-3 with templates 2O6X and 3BWK 
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Figure B-4 The alignment for vivapain-2 with templates 2O6X and 3BWK 
 
 
Figure B-5 The alignment for P. knowlesi with templates 2O6X and 2OUL  
 
 
Figure B-6 The alignment for P. berghei with templates 2O6X and 2OUL  
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Figure B-7 The alignment for chabaupain-2 with templates 2O6X and 2OUL  
 
 
Figure B-8 The alignment for chabaupain-2 with templates 2O6X and 2OUL  
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II. Scripts for modelling  
 
 Script used to run the automodel class that generates models. 
 
 
 
 Scripts used to calculate Dope-Z scores. Script written by Matthys Kroon 
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 Script used to sort models in descending order by their Dope-Z scores. Script 
written by Matthys Kroon 
 
 Script used for loop refinement, script written by Rowan Hatherley 
 
